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ABSTRACT 
 
Iron is a pivotal element for energy production and cell growth. In addition, iron 
is an important regulator of the immune system. Endocytosis of iron-loaded 
transferrin via its receptor (transferrin receptor, TfR) is a major route for the 
delivery of iron molecules into the cytoplasm. Dendritic cells (DCs) are 
prominent antigen presenting cells and key regulators of adaptive as well as 
innate immune responses. Yet, little is known about the functional role of TfR 
(CD71) on DCs. Therefore, the aim of this study was to analyze the impact of 
CD71 on differentiation and maturation of human, monocyte-derived DCs with 
four monoclonal antibodies (mAbs) directed against CD71. All CD71 mAbs used 
in this study – mAb VIP-1, 5-528, 15-221 and 13-344 – strongly reacted with 
CD71+-transfectants and with proliferating cells including human lymphoma 
cells, which are known to express high levels of CD71. Epitope analysis 
performed by cross-inhibition experiments showed overlapping binding sites for 
mAb 5-528 and mAb VIP-1, whereas mAb 13-344 and mAb 15-221 were found 
to be directed against distinct epitopes on CD71. Analyses of TfR expression 
during DCs differentiation revealed only low levels on immature DCs but a 
strong upregulation upon activation of DCs with bacterial products such as LPS. 
However, addition of none of the four CD71 mAbs modulated or inhibited either 
the differentiation of precursor cells into DCs or the maturation process, which 
was analyzed by the expression of informative cell surface receptors (CD1a, 
CD83), by the cytokine production (e.g. IL-12) or by testing the T cell stimulation 
capacity of DCs treated with CD71 mAbs. However, when mAbs VIP-1 or 15-
221 were added directly to a mixed leukocyte reaction (MLR), both mAbs 
markedly reduced T cell proliferation. Since development and activation was not 
directly influenced by a strong down-regulation of CD71 receptors from the 
surface of DCs upon mAb binding, we hypothesized that mAb VIP-1 and mAb 
15-221 might inhibit the proliferation directly via T cells. To further investigate 
this, we activated T cells via CD3 mAbs alone or in combination with CD28 or 
CD63. T cell proliferation was inhibited in the presence of mAb VIP-1 or mAb 
15-221. Beside T cell proliferation, there was also a clear reduction in the 
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production of IL-10, IL -13, IL-17 and IL-22 cytokines by mAb VIP-1 or mAb 15-
221, whereas secretion of IL-2 was only diminished in the presence of mAb 15-
221. In summary, CD71 is seemingly not critical for DC differentiation and 
maturation but is important during DC induced T cell proliferation at the T cell 
side. 
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Zusammenfassung 
 
Eisen ist ein lebenswichtiges Element für die Energieproduktion und das 
Wachstum von Zellen. Endozytose von Eisen beladenen Transferrin über den 
jeweiligen Rezeptor (transferrin Rezeptor, TfR) ist die wichtigste Route für die 
Aufnahme von Eisenmolekülen in das Zytoplasma. Dendritische Zellen (DZ) 
sind bedeutende Antigen präsentierende Zellen und Schlüsselregulatoren 
sowohl für die adaptive wie auch angeborene Immunantworten. Bisher ist noch 
wenig bekannt über die funktionelle Rolle von Transferrin Rezeptoren (CD71) 
auf DZ. Daher lag das Ziel dieser Studie auf der Untersuchung  der Auswirkung 
von CD71 auf Differenzierungs- und Reifungsprozesse von menschlichen 
Monozyten abstammenden DZ mittels vier monoklonalen Antikörpern (mAk), 
welche an CD71 binden.  Alle in dieser Studie verwendeten CD71 mAk – mAk 
VIP-1, 5-528, 15-221 und 13-344- interagierten stark mit CD71+ -
Transfektanten, sowie mit proliferierenden Zellen, einschließlich menschlichen 
Lymhoma Zellen, von welchen bekannt ist, dass sie eine hohe Anzahl an CD71 
exprimieren. Epitop Analysen mittels Cross-inhibierungs Experimente zeigten 
überlappende Bindungsstellen für mAk 5-528 und mAk VIP-1, wohingegen mAk 
13-344 and mAk 15-221 an unterschiedliche Epitope von CD71 binden. 
Untersuchungen der TfR-Exprimierung während der DZ Differenzierung 
ergaben nur eine geringe CD71 Protein Verteilung auf unreifen DZ, hingegen 
aber eine verstärkte Exprimierung nach der Aktivierung von DZ mit bakteriellen 
Produkten wie LPS. Dennoch, keiner der vier mAk modulierte oder inhibierte die 
Differenzierung von Vorläuferzellen in DZ oder beeinflusste dessen 
Reifungsprozess, was durch die Untersuchung der Exprimierung von 
Oberlfächenrezeptoren  (CD1a, CD83) und Zytokin Produktion (z.B.: IL-12) 
überprüft wurde, sowie durch das Testen der Fähigkeit T Zellen zu stimulieren 
nach DZ Inkubation mit CD71 mAk. Dennoch, wenn mAk VIP-1 oder 15-221 zu 
Beginn einer gemischten Leukozyten Reaktion (MLR) hinzugegeben wurden, 
reduzierten beide mAk deutlich die T Zell Proliferation. Da weder Entwicklung, 
noch die Differenzierung beeinflusst wurde durch eine deutliche Unterdrückung 
der CD71 Exprimierung auf der Oberfläche von DZ aufgrund der Bindung von 
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mAk, vermuteten wir eine direkte Inhibierung der T Zell Proliferation durch mAk 
VIP-1 und mAk 15-221. Um diese Möglichkeit zu untersuchen aktivierten wir T 
Zellen mittels CD3 mAk alleine oder in Kombination mit CD28 oder CD63, was 
in Verbindung mit mAk VIP-1 oder mAk 15-221 wiederum zu einer klaren 
Inhibierung der T Zell Proliferation führte. Neben der T Zell Proliferation 
detektierten wir auch eine klare Reduktion in der Zytokin Produktion von IL-10, 
IL-13, IL-17 und IL-22 während der Inkubation mit mAk VIP-1 oder mAk 15-221, 
wohingegen die Sekretion von IL-2 nur mit mAk 15-221 reduziert wurde. 
Zusammenfassend scheint CD71 nicht entscheidend zu sein für die 
Differenzierung und Reifung von DZ, jedoch dürfte es eine wichtige Rolle in der 
DZ induzierten T Zell Proliferation spielen,  besonders auf T Zellen.  
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1. INTRODUCTION 
 
1.1. Functional aspects of iron molecules in the cellular 
environment 
Iron belongs to the group of essential trace elements and plays an important 
role for the survival of each cell. Especially in mammalians, the probably most 
well-known function of iron molecules is connected with the transport of oxygen 
via red blood cells [1]. An important function of non-heme conjugated iron is 
based on the formation of electron transport chains (ETC) within the 
membranes of chloroplasts and mitochondria and the functionality of enzymes 
of the citrate cycle [15]. Coordination complexes consisting of metal ion-protein 
associations and their conjugated organic ligands are the main components of 
ETC and finally permit the production of ATP through the progression of redox 
reactions. These redox reactions are facilitated by the electron transfer between 
electron donor Fe(II) and electron acceptor Fe(III) complexes [1]. Other 
prominent members of non-heme metalloproteins form iron-sulfur complexes 
and find applications in regulatory processes of the gene transcription and in the 
stabilization of protein structures [6, 10]. Catalytically active proteins with iron 
components are also important for DNA synthesis through the action of 
ribonucleotide reductase enzymes [1, 4] and in the disarming of free radicals via 
different dismutases [16].  
Especially in the ferric form (Fe(III)), iron also has harmful effects for cells [1, 2, 
10]. Combined with unsaturated fatty acids, iron participates furthermore in the 
appearance of alkoxyl radicals [16]. Under aerobic conditions, iron oxidation 
processes catalyze the production of hydroxyl radicals (also known as Fenton 
and Haber Weiss-chemistry [1, 2, 10] ). OH. Radicals produced in Haber Weiss 
reactions are also described as “reactive oxygen intermediates“ (ROIs). 
Accumulation of ROIs leads to mutation in the bases of nucleic acids, lipid 
structures and protein composition [1, 7]. These destructive effects are 
selectively used by phagocytes to avert bacterial spreading within the host 
tissue. Monocytes and phagocytes produce active ROIs via the membrane 
anchored NADPH oxidase complex [1, 2, 27]. Beside bone marrow cells, 
hepatocytes, enterocytes and myocytes, reticuloendothelial macrophages 
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participate also in the storage of iron particles [1, 10]. Based on these facts, iron 
absorption is essential for the growth and segmentation of cells, but also carries 
the risk of damaging host body cells.  
1.2. Iron absorption from food by the human duodenum and 
further transport through blood circulation 
Human duodenum apical membrane cells assimilate daily 1-2 mg iron from food 
to serve essential functions of the body [1]. High iron concentrations are 
detectable in liver, muscle cells (myoglobin) and in bone marrow, where iron 
atoms are integrated into porphyrin rings during the production of red blood 
cells [1]. After food intake, ferrous iron atoms (Fe(II)) are bound by divalent 
metal transporter 1 (DMT1, also referred as Nramp2 or DCT-1) and guided 
through the duodenal epithelium [1, 10]. Structural analysis of DMT1 resulted in 
12 membrane spanning proteins which allow the transport of various ions 
across the double layer membranes [16]. Enterocytes permit not only the 
storage of iron in form of ferritin but also the further transport into the blood 
stream via ferroportin-1 (also termed as IREG1 or MTP1) membrane transport- 
proteins [1, 5]. Ferroportin-1 is just as DMT1 a membrane spanning protein 
consisting of 10 domains within of the membranes [16].  
An iron metabolism control hormone, hepcidin, gets produced in the liver and 
has negative regulatory functions for the ferroportin-1 transport mechanism via 
reduction of iron absorption [5]. Before the ferroportin-1 export starts, ferrous 
iron atoms are oxidized by ferroxidase hephaestin. This oxidation process 
results in a ferric iron state (Fe(III)) and permits its fixation at apo- (serum) 
transferrin (Tf) glycoproteins [5, 16]. 
Tf is composed of two subunits (N- and C- lobe) and each half can carry one 
iron molecule within a hydrophilic gap between the upper and the lower part of 
each lobe [7]. Both fragments are connected via 13 disulfide bridges [16]. Iron 
attachment into the gaps causes a conformational change within of Tf proteins 
and permits the transport through the blood stream into the rest of the body [7, 
9].  
Fixation of Tf to its receptor is assumed to occur at least at two locations, one 
C-lobe and one fixation point on the N-lobe [7]. The binding affinity of Tf to its 
INTRODUCTION 
 
15 
 
receptor is noticeably high [7]. The Tf coding sequences have been changed 
only to a small degree in the course of the evolutionary development among 
different species [7, 46]. Tf peptides have been highly conserved as single-
chain iron transport proteins and production in hepatocytes is amplified [7, 16]. 
In general, there are three known Tf variants: Serum Tf has been found in 
various body fluids of mammalians, ovotransferrin is mainly distributed in avians 
and reptilians and lactoferrin proteins are components of saliva and milk [7]. A 
further membrane anchored homologous protein to the Tf group is called 
melanotransferrin (MTf). It has been discovered on surfaces of mammalian and 
avian cells and seems to be connected with the iron transport through the 
blood- brain barrier [16]. MTf binds also other metals beside iron and get 
translated through a different mechanism compared to the Tf protein production 
[16]. However, MTf is also known as melanoma tumor antigen p97 based on its 
overexpression especially on melanoma cells [8]. 
1.3. Transferrin cell surface receptor- structure and function 
 
1.3.1. Transferrin receptor 1 (CD71) 
The transferrin receptor 1 (TfR1) can be found on nearly all nucleated cells and 
is composed of two identical glycoprotein trans membrane subunits [6, 7]. For 
the order of primates seven homologous receptors are described [17]. Each 
subpart has a molecular weight of 90 – 95 kDa and both monomers are 
connected via disulfide adhesions [6]. The disulfide bridges are located in the 
extracellular receptor part directly after the cell membrane and include cysteine 
residues 89 and 98 [6, 7, 16]. Based on short cytoplasmic N-terminal tails, TfR 
homodimers belong to the type-2 trans membrane proteins. The large C-
terminal ectodomain of both monomeric subunits interacts with the iron loaded- 
Tf complex in at least two amino acid moieties (Tryptophan641 and 
Phenylalanine760 [6]). 
The extracellular receptor part exhibits a trypsine attackable region and can be 
displaced into the serum [7]. Hence it lacks cytoplasmic TfR tails and single 
pass transmembrane domains in soluble serum TfRs [3]. The functions of the 
soluble receptor components are not completely clear, but probably its 
effectiveness relies on regulatory mechanisms. Approximately one third of all 
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produced TfR proteins reside on the cell surface, the other parts remain in the 
cytoplasm within endosomes or are delivered into the circulation [3]. 
In the membrane bound variant, three N-linked glycosylation sites and one O- 
linked glycosylation site have been characterized in the C-terminal region [6, 7]. 
These areas are essential for the correct functionality of the receptor, including 
the correct folding mechanism. A short hydrophobic single-pass trans 
membrane domain connects the N-terminal and C-terminal part of the 
respective units (Figure 1) [6]. Each monomer of the TfR complex encompasses 
760 amino acids [9]. The cytoplasmic component of the receptor complex 
comprises the internalization sequence (2OYTRF23) that is required for 
endocytotic iron absorption mechanisms [16]. TfRs bind not only Tf but also 
HFE, a protein complex associated with the control of iron absorption [16]. The 
posttranslational regulation of receptor expression is further associated with the 
assembly of iron storage proteins and assures increased surface expression 
during low iron levels within the cytoplasm (Figure 3).  
Beside the ingestion of metal ions, TfRs exhibit also regulatory functions for the 
immune system by attaching IgA1 antibodies as well as in the interaction with 
antigen receptors of immune cells [6, 24].  
  
Figure 1: Structural composition of the human transferrin receptor 1 (TfR1). The 
homodimer is joined together via disulfide bridges arising from two cysteine residues at the 
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beginning of the extracellular domain. The large extracellular C-terminal domain is further 
categorized into a protease-like, apical and helical part. The latter one forms a binding cleft for 
iron loaded Tf proteins. Asp251, Asp317 plus Asp727 exhibit N- linked glycosylation sites (black 
circles) and Thr104 an O- linked gycolysation site (black triangle). All glycosylation sites are 
probably important for the correct shape of the receptor, but definitely for the internalization 
process. The extracellular domain can be cleaved in the stem area and delivered into the 
circulation. Each monomer encompasses 760 amino acids. Figure is adapted from Daniels et al. 
[6] 
1.3.2. Translation of the TfR 
The translation of the TfR is coupled to the actually available iron concentration 
of the cell. In humans, both TfR and Tf are coded on chromosome 3 [3, 16]. The 
3` untranslated region (3`UTR) of the TfR mRNA includes 5 hairpin stem loop 
structured iron response elements (IREs) [6, 7]. The translation step of the IREs 
is inhibited by loop structures. Even if iron regulatory proteins (IRPs) bind to 
IREs, the loop structures are pulled apart and the TfR mRNA is available for the 
translation [1, 7]. The same regulatory system also plays an important role for 
the translation of DMT1 proteins [16]. IREs contain a 28-nucleotide consensus 
sequence whereas the remaining mRNA structures are species specific [16]. 
IRP-1 and IRP- 2 are the key proteins concerning the sensing of the intracellular 
iron concentration [10, 16]. IRP-1 enzymes are constructed of 4Fe-4S clusters 
and manifest sequence identity with the mitochondrial aconitase, which in its 
active form catalyzes the rearrangement of citrate into isocitrate [6, 10]. Low 
concentrations of iron atoms avoid the function of these enzymes and IRP-1 
proteins bind to IREs. This process leads to the stabilization of the TfR mRNA 
and to its translation [1]. IRP-2 also binds TfR mRNA, but exhibit no catalytic 
activity [16]. Its sensing effect depends mainly on the oxygen and iron 
concentration and is neutralized in cells with low iron concentration via 
proteosomal degradation [1, 6]. Based on trials with IRP-1 deleted mice, it is 
assumed that IRP-2 may counterbalance IRP-1 deficiency [7]. Both IRPs 
equally act in the translation of ferritin iron storage proteins but contrary to the 
TfR mRNA, IRP- 1 and IRP- 2 prevent the translation start up to of the 5`UTR 
region [6].Synthesis of TfR1 occurs in the endoplasmic reticulum [7]. Oxidative 
stress, especially in form of extracellular H2O2 or nitric oxygen, has also positive 
consequences for the activation of IRPs and leads to its binding not only at IRE 
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sequences on the mRNA of TfRs, but also of ferritin [10]. Hence oxidative stress 
leads to stronger expression of TfRs but also to reduction of iron storage 
proteins whose IRP mediated translation is contrary regulated to TfRs [11, 16].  
1.3.3. Hereditary hemochromatosis protein (HFE) allows the 
 negative regulation of iron absorption 
HFE participates in the regulatory mechanism of iron absorption by occupying 
the CD71 binding sites [16]. The hereditary hemochromatosis proteins (HFE) 
show a similar structure to the major histocompatibility complex 1 (MHC I) 
including the β2- microglobulin (β2m) structure [6, 9]. On the cell surface, it 
blocks the binding sites for Tf proteins within the helical domain and does not 
dissociate until the pH becomes acidified in the newly formed endosome [7, 9]. 
Hereditary hemochromatosis is a well-known defect in the HFE gene. In this 
case HFE proteins are not capable of inhibiting the permanent iron absorption 
and result in tissue and organ damages. However, there are also 
hemochromatosis diseases known independently of HFE gene mutations [16].  
1.3.4. Transferrin receptor 2 
LikeTfR1, TfR2 is also a type II transmembrane receptor [17]. Compared to 
TfR1, the translation process of TfR2 is not controlled via the attachment of IRP 
enzymes to IREs [6]. At the transcription level, two different receptor variants 
are produced by alternative splicing. TfR2α exhibits similar C- terminal 
ectodomains compared to TfR1, but completely different cytoplasmic and trans 
membrane regions [6].It is mainly distributed on liver cells and seems also to be 
important for the development of erythrocytes [7]. In TfR2β proteins, the trans- 
membrane and the cytoplasmic regions are completely absent [6]. The 
internalization sequence of TfR2α exhibits also slight modifications [16]. Tissue 
cells express higher levels of TfR1 proteins than TfR2 receptors, but it seems to 
play an important function in the development of liver tissue and erythroid cells 
[7]. Iron loaded Tf has a significant higher binding affinity for TfR1 than for TfR2 
[7]. Higher levels of TfR2 are detectable in enterocytes of the small intestine 
and in hepatocytes [6]. Mutations in TfR2 proteins cause a HFE independent 
hemochromatosis variant and lead to the suspicion that iron excess charge is 
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related to TfR2 damage and that TfR2 exhibits important functions in the iron 
circulation [7, 17].  
1.4. Receptor mediated iron absorption and transport into the cell 
interior 
Shortly after the reduction of Fe(III) via duodenal cytochrome b (Dcytb), Fe(II) is 
gated into enterocytes via DMT1, again oxidized by the action of hepaestin and 
exported into the circulation via ferrroportin 1, where Tf proteins integrate up to 
two iron molecules for the transport through the circulation [1, 7]. Ferroportin 1 
mediated exportation of iron molecules after passing the enterocytes is also 
employed by macrophages [10, 15]. In both cell types, the export process is 
negatively influenced by hepcidin, a hormone produced by liver cells [10]. Tf 
proteins charged with two iron molecules offer a higher receptor binding affinity 
than just single charged transport glycoproteins [6]. Based on the restructuring 
processes after ion attachment, Tf components without linked iron molecules 
bind not or only marginally to the receptor and are not integrated into the cell 
interior [10]. Absorption into the cell interior of Tf conjugated non-heme iron 
molecules is facilitated by their interaction with cell surface TfRs [1, 6, 9]. The 
Tf-TfR complex is integrated through endocytosis and clathrin- coated pits 
constitute the envelope of the newly forming endosome [6]. Beside the declining 
pH (from pH 7.4 on the cell surface down to pH 5.5) in the endosomal 
environment, the interaction between amino acid residues Tryptophan641 and 
Phenylalanine760 on the C-terminal ectodomain of the receptor as well as 
Histidine349 remnant on the Tf molecule itself causes a structural change of the 
Tf glycoproteins and enhance therefore the dissociation of the Fe(III) atoms [6, 
9, 10]. Free ferric iron molecules are repeatedly reduced to Fe(II), exported from 
the endosome in a DMT1 dependent manner and as a result arrive at the 
cytoplasm of the cell. One part of the non-heme iron atoms are integrated in 
diverse enzymes such as in aconitases, cytochromes or RNA reductases [7]. 
Another part is kept in iron storage cells. Unconjugated Tf (Apo- Tf) and its 
receptor remain bound in the endosome and return in a further step back to the 
cell surface. Dependent on the higher pH (pH 7,4) at the cell surface, apo- Tf 
dissolves from the receptor and enters again the circulation [7]. The course of 
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one cycle needs approximately 10 minutes [3]. Receptor inclusions into 
endosomes occur often also without conjugated Tf and indicate that there is no 
correlation between the conjugation of Tf to its receptor and the internalization 
process [6, 13, 14].  
 
Figure 2: Each Tf protein transports maximally 2 iron atoms and is integrated into the cell 
via linkage to the TfR. HFE proteins compete with Tf for the TfR binding sites.  Endocytosis 
occurs by the accumulation of clathrin coated pits on the inner cell membrane around the 
receptor integration area. The newly formed endosome is acidified via the influx of H
+
 atoms, 
whereby the Tf molecules change their shape. Freed iron molecules are gated through the 
endosomal membrane via DMT1 proteins and cytoplasmic iron atoms are integrated into 
various enzymes or stored in ferritin protein complexes. Receptor and Tf remain conjugated and 
return back to the cell surface, where both components dissociate again. Schema is adapted 
from Qian et al. [7] 
1.5. Cell internal iron storage via ferritin complexes 
Most of the assimilated iron is not required immediately. Iron storage 
mechanisms have evolved evolutionary to prevent an excess of the harmful 
metal molecules within the mammalian body. Iron storage proteins, also 
referred as ferritin, form complexes with iron atoms and are accumulated mainly 
in enterocytes, hepatocytes and reticuloendothelial macrophages [10, 15]. 
Altogether the whole protein complex encompasses 24 subunits [1, 16]. The 
translation of the Ferritin protein complexes is based on the same principle as 
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mentioned before for the expression of the TfR, but contrary to the receptor 
translation, the functional IRP-1 enzyme based on iron integration into the 
enzyme complex prevents its binding to the ferritin mRNA and permits therefore 
the translation of ferritin proteins (Figure 3) [1, 6, 15]. Point mutations especially 
in the IREs of the L- ferritin lobe result in the development of diseases, such as 
hyperferritinemia [16].  
Each ferritin complex can retain up to 4500 iron molecules [16]. Ferritin exists 
also in the cytoplasm in glycosylated form and exhibits higher levels during 
inflammatory processes [16].  
Comparable to the opposite consequences of iron molecules on the translation 
process of TfRs and ferritin proteins, cytokines show comparable effects. Most 
of the ferritin translation enhancing cytokines exhibit simultaneously inhibitory 
effects on the expression of receptor proteins and vice versa [15].  
 
 
Figure 3: The regulatory mechansims of the translation of Tf and ferritin mRNA is based 
on the same principle, but ends up with opposite results. For the  translation of both protein 
variants, iron regulatory proteins (IRP) bind to iron regulatory elements (IRE) in the 3`and / or 
5`UTR of the TfR and  ferritin mRNA. A) Low intracellular iron concentration leads to the 
dissociation of iron sulfur complexes from IRP-1 plus to the synthesis of IRP-2. IRPs bind to 
IREs in the 3`UTRs of the TfR mRNA as well as to IREs in the 5`UTR of the ferritin mRNA. 
A 
B 
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Binding of IRP stabilizes stem loop structures in the TfR mRNA und permit protein synthesis. 
On the other hand IRP attachment to IREs in the 5`UTR of the ferritin mRNA prevents its 
translation. B) Increasing intracellular iron concentration leads to a functional aconitase- like 
enzyme and inhibits the function of IRP1 proteins. Iron leads equally to the ubiquitination and 
consequently to the destruction of IRP2 proteins. Therefore the TfR translation remains inhibited 
through stem loop structures in the 5`UTR, whereas the coding regions of ferritin mRNA is 
available for its translation. Figure is adapted from Daniels et al. [6]  
1.6. Iron has important immunoregulatory functions  
The expression of Tf coupled with the iron absorption system has further 
important functions in the establishment and regulation of the mammalian 
immune system. In TfR attachment experiments Moura et al [18] observed an 
increased binding affinity for monomeric IgA1 antibodies in epithelial cells and 
mesangial cells. This antibody specificity may allow an immunoregulatory 
capacity beside the iron transport mechanism [6]. The absorption of iron is 
necessary for the activation process of nearly all immune cells. Therefore it is 
assumed that TfRs participate in the activation events of B- and T- cells [18-21] 
and participate further in the maturation process of DCs [5]. Especially for the T 
cell activation it is supposed that TfRs potentially exert influences on the signal 
transduction of the T- cell receptor (TCR) by the direct interaction on the ζ- 
chains and participate actively in the construction of immunological synapses 
[22].  
1.7. Dendritic cells and their function in the human immune 
system 
Dendritic cells (DCs) belong to the important group of antigen presenting cells 
(APCs) of the mammalian innate immune system [23]. The function of APCs 
relies on the recognition and phagocytosis of foreign peptides as well as in the 
detection of damaged self- tissue. Antigen detection and admission occur via C- 
type lectin receptors (mostly langerin or mannose receptors), scavenger 
receptors and most often via Fc and pattern recognition receptors [23, 24]. DCs 
are categorized into the innate immunity, but they are also characterized as 
important transitional immune cells based on their ability to activate cells of the 
adaptive immune system. Phagocytic peptides are processed and loaded onto 
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MHCs to afford their presentation to naive T- cells [24]. Classical peripheral 
DCs emerge from bone marrow precursor cells, mostly from CD34+ 
hematopoietic stem cells inside of bone marrow [25]. Dendroid appendages 
facilitate the capture of possible pathogens. Antigen catching occurs by the 
recognition of evolutionary conserved molecular patterns, also described as 
pathogen- associated molecular patterns (PAMPs). Detection of PAMPs is 
performed by pattern recognition receptors (PRRs) [23]. Absorption of antigen 
leads to the startup of a standardized programme, which includes the 
maturation to professional APCs resulting in a strong expression of MHC class 
II molecules as well as to the strong expression of costimulatory B- and T- cell 
activation proteins (CD40, CD54, CD58, CD80, CD86) on cell surfaces [5, 23]. 
In the same context, DCs start to migrate to secondary lymphoid organs to 
allow an efficient antigen presentation [23]. Receptor mediated antigen 
recognition additionally activates signal transduction pathways for the initiation 
of cytokine production [23]. Functional aspects of cytokines on other cells are 
discussed below. In vitro studies often use CD14+CD11c+ blood monocyte 
derived DCs. CD14+CD11c+ monocytes can be kept in liquid nitrogen for a long 
time period and monocyte derived DCs are obtained five days after treatment 
with GM-CSF and IL-4 [5, 25]. Actually two more main groups of dendritic cells 
are defined: Plasmacytoid DCs are important type 1 interferon producers and 
are specialized for the defense against viral infections, whereas Langerhans 
cells (LC) are positioned in epithelial layers to absorb fast infiltrating pathogens 
[23]. 
1.8. Iron molecules are important cofactors for dendritic cell 
maturation 
Analysis of freshly isolated monocytes demonstrated only hardly detectable 
numbers of TfRs on the surface [24, 27]. Cultivation in an iron containing 
medium leads to an increase of the receptor proteins within of 3 days and is in 
contrast to the previously described TfR expression regulatory mechanism for 
proliferating cells [4]. Expression of higher protein levels of TfRs and DMT1 
leads to the accumulation and storage of iron molecules within the DCs. TfR 
and DMT1 proteins are oppositely regulated to low expressed Ferroportin-1, the 
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iron export molecule [5]. Ferroportin-1 appears up to 70% lower in DCs than in 
other cells [5]. This protein arrangement is intensified during the maturation 
process to professional antigen presenting cells (APCs) [5]. The variety of 
stimuli seems not to be important for the up- regulation of CD71 proteins. 
Pasquier et al. reported 2004 [24] that TfR proteins on the surface of DCs 
achieve additional functions in the detection of IgA immunoglobulins and 
mediate the endocytosis in immature and activated DCs. Dimeric and also 
polymeric IgA is delivered in an amplified fashion by plasma cells mainly 
residing in the intestinal laminia propria, transported via the blood stream and 
further emitted by mucosal cells to detect antigens on mucous membranes [26]. 
The monomeric variant of this immunoglobulin isotype (IgA1) predominant 
within the human body is frequently encountered in blood serum and is 
recognized by CD71 and other receptors [24]. 
1.8.1. Macrophages belong to the iron storage cells 
Beside enterocytes and hepatocytes, monocyte derived macrophages are the 
most important iron storage cells [1, 10]. Therefore macrophages express 
mostly high levels of surface TfRs. However, macrophages gather most of the 
iron from the destruction of senescent erythrocytes [2, 10]. Macrophages fulfill 
this process more efficient than monocytes, which is also referred as 
erythrophagocytosis. Most of the recovered iron molecules are integrated into 
protein complexes (hemoglobin, myoglobin or Tf) and are exported back into to 
the cytoplasm [2]. Macrophages and also many other immune and non- 
immunogenic cells of mammals express additional to TfRs also lactoferrin 
receptors [15]. Lactoferrin also belongs to the Tf family and offers another 
possibility also for iron absorption. Lactoferrin has additional regulatory 
functions for the augmentation of NK- cells, lymphocytes and monocytes and 
supports the immune system to prevent the spreading of bacteria [2, 7].  
Beside the toxic components of iron molecules, the excessive charge has also 
negative effects for the immune function of macrophages, because it blocks 
IFNγ- mediated pathways [2, 15]. For that reason the production of NO, the 
secretion of IFN-α as well as the translation of MHC II proteins does not work [2, 
15]. An increased iron concentration in the body affects also the production of 
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granules through neutrophile granulocytes and monocytes based on a 
malfunction of the inducible nitric oxide reductase (iNOS) [1, 15]. Malfunction of 
the regulatory system for the iron absorption diminishes therefore the defense 
mechanism for the killing of invaders. Similar to the previous described effects 
of cytokines referring the TfR and ferritin storage protein translation, IFN-γ 
pretreatment of macrophages prevents the surface appearance of TfR on cell 
surfaces as well as the translation of ferritin proteins [28, 29]. Cytokines derived 
from the TH2 subgroup neutralize the effect of IFN-γ treated and activated 
macrophages and enforce the iron absorption and attachment to ferritin proteins 
[15].  
1.8.2. Tf and TfR independent iron absorption mechanisms 
 
Experiments demonstrated a sufficient iron supply in a Tf free cell environment 
particular for liver cells, HeLa and Raji cells [64]. Beside the conventional iron 
absorption with CD71, endocytosis of iron molecules without intermediate TfR 
proteins are assumed for cells of healthy tissues, e.g. for reticulocytes and 
hepatocytes [66]. Melanoma cells express p97 proteins similar to Tf and are 
known to gate iron molecules into the cell [65]. The integral membrane protein 
SFT is also supposed to transport iron into the cell interior and further to 
stimulate its uptake via Tf dependent and independent mechanism [7, 16]. 
Furthermore experiments with B Cell lymphoma have shown that cells 
incubated in a Tf- free, but iron salt containing medium exhibited no effects on 
the iron dependent cell growth [64]. The alternative iron absorption system 
seems to permit also the uptake of other metal elements and is strongly 
expressed at low iron salt concentrations [64, 68]. Previously studies on 
fibroblasts demonstrated an increasing concentration of intracellular Ca2+ level 
after binding of transition metals to its belonging receptors. Therefore Kaplan 
and collegues [68] assume that strong intracellular Ca2+ concentration may 
influence the intensity of the non- iron transport mechanism. Further 
observations of various cell types showed also a temperature and time 
dependency for the alternative iron absorption [64, 68]. Actually some models 
attempt to explain the iron absorption mechanism independently of Tf 
conjugation or receptor attachment [64-66]. However, the mechanisms of Tf or 
TfR independent iron absorption are not completely understood and seem to 
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depend on the respective cell type. Yet it is obvious that iron uptake exclusively 
via Tf independent mechanisms alone are insufficient to sustain erythropoiesis 
and important cellular functions within the mammalian body [16].  
1.8.3. Iron influences the progression of infections and cancer 
 diseases 
The intracellular iron concentration affects the mammalian immune system in 
many ways. A low total iron concentration causes an uncontrolled development 
on B and T lymphocytes, especially in the proliferation step between the already 
functional first receptor chain and the incompletely arranged second one [15]. 
The missing proliferation step results in minimal or only in a strongly limited 
number of antigen specific immune cells [20, 62]. Further degradation of the 
immune system concerns the defense mechanism of phagocytes, macrophages 
and monocytes. Iron is necessary for the function of the NADPH complex to 
produce ROIs [1, 2, 15]. Iron deficiency affect also the activation process in 
most of the other immune cells. On the other side it is known that iron loaded 
macrophages lose their killing function based on the transcriptional inhibition of 
iNos as well as their qualification of cytokine producing cells [2, 15]. The 
strongly weakened immune system makes it easier for invaders to propagate 
and to spread in the whole host. On the other hand, bacteria and other 
extracellular invaders, except for viruses, are equally dependent on the iron 
concentration and are therefore also inhibited in their growth [2].  
Increased iron concentrations offer invaders an optimal initial point for the 
assimilation of this trace element. The immune system developed various 
strategies to remove iron and to inhibit the growth of pathogens. One 
mechanism relies probably on the strong production of Hepcidin, the liver 
derived hormone, which prevents the iron export from enterocytes and 
macrophages by interacting with ferroportin 1 proteins [10]. High iron 
concentration affect the immune system in a similar way, lead to malfunctions of 
many immune cells and furthermore to a strong adjustment of the TH1 and TH2 
cytokine dispersal [15]. Both low and high iron concentration reduce the 
monitoring function of the immune system concerning diverse invaders but also 
in regard of malfunctions of host body cells [15]. The reactivity of unconjugated 
iron molecules to form hydroxyl radicals and the increased availability for the 
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integration in enzymes of proliferating cells combined with a suppressed 
immune system probably enhances the formation of diverse cancers [15]. 
1.8.4. Therapeutic application linked to the iron absorption 
 mechanism 
Since the end of the last century, the TfR was considered for use its specific 
form of transport in the drug therapy for the treatment of different diseases, 
especially in cancer therapy. Already in 1981 Trowbridge and Domingo [69] 
observed inhibitory effects on the growth of human lymphatic tumor cells by the 
application of Ricin A conjugated mAb B3/25 (IgG isotype) directed against the 
TfR. Further experiments showed a strong tumor cell growth inhibition by the 
utilization of mAbs alone or in combination with other mAbs directed against TfR 
and led to the assumption that iron deprivation is the most effective mechanism 
to reduce tumor growth [49, 72]. A notably inhibitory effect has been achieved 
via the application of mAb 42/6 (IgA isotpye) that is assumed to compete 
efficiently for the Tf binding site on the external part of the TfR [70, 71] or to 
cross- link several surface receptors [72]. Both mAb variants reduce Tf binding 
sites, but only mAb 4/25 efficiently inhibits the receptor dependent uptake of 
iron-Tf complexes [73].  
Other trials are based on the fact that Tf also carries metal ions different from 
iron, such as diagnostical, therapeutic (BI3+, Ru3+, Ti4+), platinum complexes or 
toxic metal ions [7]. In the circulation of the human body, only 30% of the 
human Tf proteins are charged with iron and the remaining proteins are 
available to bind different metal ions. The biggest benefits of drug transport via 
TfRs rely on the non-immunogenic and nontoxic characteristics of the protein 
components as well as the high appearance on rapidly and often proliferating 
cancer cells [7]. Further approaches for more site specific delivery of 
pharmaceutical products are based on the conjugation to the Tf protein 
complex. Chemical linkage and protein engineering are two promising methods 
to assure the directed delivery of drugs into the cell interior [7]. The Tf protein is 
also a promising tool to insert DNA sequences into target cells [7]. The 
transfection via Tf mediated endocytosis is neither toxic nor infectious contrary 
to some of the common transfection methods. Probably most approaches in the 
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cancer therapy referring to this use the linkage of mAbs directly on surface 
epitopes of TfRs [7].  
1.9. T- cell activation via APCs 
T cell precursor cells are produced in the bone marrow and arrive in the thymus 
for maturation. During the developmental steps in the thymus, T cells are also 
called thymocytes [23]. Mature T cells are categorized into the 2 main groups 
based on the different expression of coreceptors, which are necessary for the 
activation process [86]. APCs evolve equally 2 MHC variants to permit the 
interaction with the main groups of T cells. MHC molecules exhibit highly 
polymorphic antigen binding sites and affix to only one specific antigen 
combination specific [23].  
Differentiated CD4+ effector T cells are especially required for the activation of 
diverse immune cells such as B cells, macrophages and CD8+ T lymphocytes 
through the generation of diverse cytokines and chemokines [2, 23]. Based on 
specific cytokine profile and the effects of the soluble proteins on the total 
immune system, CD4+ T helper cells are categorized in further subgroups. 
Blocking studies of the TfR via mAbs on the two main CD4+ T cell subgroups 
exhibit a clearly easier and stronger inhibition of the TH1 line as for the TH2 
subgroup [2]. The second major group of T effector cells express CD8+ 
costimulatory surface molecules conjugated to the T cell receptor (TCR) and 
are specialized to prevent the spreading of intracellular pathogens via secretion 
of cytotoxic granules [23]. The recombination process of genes required for 
various TCR chain building, the translation of the two mentioned main receptor 
types and the earlier positive and negative selection process to avoid self- 
reactivity are described elsewhere [23]. Mature, but naive T cells migrate to 
secondary lymphoid organs such as lymph nodes. Already antigen stimulated 
DCs encounter naive T cells in corresponding zones of lymph nodes, where 
APCs start to present antigens via MHC molecules [30]. Consequently activated 
T cells start to migrate to the peripheral tissue, where they achieve their 
respective effector function.  
Interaction between APCs and T cells occurs at distinct surface areas, which 
are directly connected with the cell interior via adapter proteins [23]. The 
immunological synapse (IS) on T cells is formed by two “supramolecular 
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activation clusters” (SMACs) [30, 32]. The central SMAC (cSMAC) contains the 
TCR complex in combination with the respective coreceptor and additional 
costimulator proteins. Expression of costimulatory molecules on both APC and 
DC surfaces are required for the initiation of T cell responses additional to the 
recognition of processed antigen [23, 30, 31]. The peripheral SMAC (pSMAC) 
contains integrin ligands for sufficient adhesion forces between APCs and T 
cells such as LFA-1 and ICAM [31].  
Resting T lymphocytes express only a limited number of surface TfRs. This 
number is strongly increased after detection of mitogen stimuli [31]. T 
lymphocyte activation is associated with IL-2 receptor and cytokine production 
which results in the clonal expansion of specific T cell clones. Neckers and 
Cossman [20] figured out that surrogated components for monocytes with or 
without additional mitogen activating substances stimulate T cells to manifest 
TfR expression one day after IL-2 cytokine receptor occurrence. IL-2 detection 
by type I receptors is required for the appearance of TfRs on the cell surface 
[20]. In the natural environment, the interaction between TCR and MHC 
complex combined with costimulatory surface molecules triggers the translation 
of IL-2 genes [21]. Inhibition of TfR expression by mAbs resulted in weakened 
cell growth probably based on nonfunctional DNA synthesis during the S-phase 
of the cell cycle [20]. Blocking of DNA replication based on iron deficiency can 
be explained by the replication machinery whose enzymes require iron for its 
functionality. Further analysis demonstrated a direct context of TfRs with the 
cytoplasmatic signal transduction motifs of ζ- [22] and / or CD3 chains [31] 
associated with the TCR complex. The appearance of surface TfR in ISs is 
coupled to the TCR. During the formation of the IS, surface TfRs migrate to the 
pSMAC while TCRs remain in the cSMAC [23, 31]. Inhibitory antibodies 
targeted on the Tf attachment site on surface receptors which are migrated to 
the pSMAC show a clear negative effect on the formation of the IS. Furthermore 
TfRs in endosomes are accumulated directly in front of the forming APC- T cell 
contact site and integrate probably into lipid rafts of the cSMAC [31].  
Already in 1988 it was reported that CD71 mAbs FG 1/5 and FG 1/6 bind to TfR 
of NK cells in a different area than the Tf binding site [87]. Concerning the T cell 
activation process there is only a marginally reduction detectable for mAb FG 
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1/5 [31]. The weak reduction is in contrast to the strong inhibitory effect for the 
formation of ISs by mAb FG 2/12 that compete with transferrin for the binding 
site [31, 88]. Anyway addition of mAb 1/6 lead to T cell activation, tyrosine 
phosphorylation by TfRs [22] is detectable and probably activate costimulatory 
molecules [31]. The observation of TCR ζ and CD3 chain tyrosine 
phosphorylation by TfRs showed that TfRs participate in the communication 
with the TCR [31]. Furthermore, mAbs inhibiting the Tf binding to their receptors 
inhibit synapse formation potentially through the overlapping of a special 
sequence area proximate to Tf binding site, which may offers an important 
function for the generation of IS. T cell treatment with mAb FG 2/12 results in 
the reduction of Lck recruitment and therefore to a nonfunctional signaling 
through CD3 chains [31]. Lck belongs to the Scr family of Protein tyrosine 
kinases (PTKs) and is associated with the TCR complex [33]. It offers important 
roles in the T cell activation via tyrosin phosphorylation of Immunoreceptor 
tyrosine-based activation motifs (ITAMs) on basis of CD3 and ζ chains (Figure 
4B) [23]. Therefore it is assumed that TfR may possess important signal 
transduction functions already before IS formation and participates actively in its 
formation process [31]. Beside the homologous heterodimers of the cytoplasmic 
CD3 receptor parts, both ζ chains transmit signals from TCR to activate 
transcription factors mostly of cytokine genes [23].  
TfR surface receptors are particular strongly expressed to begin of the physical 
contact between APC and TCR and associate with ζ- chains [22]. By reason 
that PTK Zap70 is activated after tyrosine phosphorylation of TCR ζ- chains, 
Salmerón et al. [22] showed that active TfRs exhibit initiating effects on the TCR 
signal transduction into the cell interior. Direct stimulation of TfR showed 
comparable signal transduction effects as described for TCR activation via 
antigen [22]. 
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Figure 4: The interaction between APCs and T cells require the formation of 
immunological synapses (IS). Formation of IS requires the participation of TfRs probably in 
signal transduction processes. A) Migration of surface TfRs into the periphery (green circle) as 
well as the integration of previous endosomal  TfRs into lipid rafts in the cSMAC (red circle) are 
essential for the formation of the IS and further for the signal transduction via CD3 chains. B) 
TfRs are probably necessary for the recruitment of PTK Lck to the TCR and in the next step for 
the tyrosine phosphorylation of CD3 and ζ chains. Adapted from [23] 
1.10. T helper cell differentiation into TH1 and TH2 subtypes is also 
influenced by cellular iron concentration 
Based on the variance of their effector function, mammalian T helper cells are 
classified into TH1, TH2, TH17 plus regulatory T cells [34, 35]. TH1 cells secrete 
mainly IFNγ and TNFβ and activate thereby not only macrophages of the innate 
immunity [15, 35]. Contrarily the TH2 subgroup enhances via cytokines IL-4, IL-
5, IL-10 and IL-13 production the B cell isotype switch to IgE secreting plasma 
cells and additionally represses the effector function of macrophages [15, 35]. 
The cell subtype differentiation occurs early in the development and is 
dependent on the respective predominant cytokine environment. The exposition 
to IL-12 or INFs during the CD4+ T cell development advances the 
differentiation to the TH1 lineage, while IL-4 cytokines induce the determination 
into the TH2 subdivision [35]. It is further assumed that iron influences the 
specialization of T helper cell subdivisions. Iron unloading studies via mAbs 
directed against the TfR verified a stronger iron requirement for the 
development of the TH1 subgroup than for TH2 cell line [15].  
A B
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1.11. B lymphocyte growth requires the expression of Tf surface 
receptors 
Similar to T cell proliferation, TfR accumulation on B cell surfaces is also 
required for B cell propagation. Resting B lymphocytes express only a low 
number of TfRs. Stimulation with B- cell growth factors (BCGFs) plus T cell 
derived mitogen stimuli result in increased fusion of TfR loaded endosomes with 
the plasma membrane [62]. Inhibition of iron ingestion by the application of 
monoclonal antibodies directed against the Tf binding sites prevent the DNA 
copy mechanism probably in the same way as already described for T cells. 
Production and disposal of diverse antibodies require stimuli by mitogen 
proteins but seem not to depend on the iron assimilation process [62]. TfR 
knock out assays in mice hypothesize that iron plays an important role already 
in early steps of the erythropoiesis and lymphopoiesis [63]. Iron deprivation after 
Immunoglobulin heavy chain expression during B cell development leads in 
some cells to functional IgM+ antibodies [63]. However, only a limited number of 
B lymphocytes were allowed to mature to effector cells and is probably 
associated with deficient proliferation of precursor B cells. Nevertheless, the 
strongest effect of mural TfR deletion was noted for T cell processing, because 
thymocytes lacking iron atoms arrest the development between the triple 
negative and the double positive growth stage [63]. 
1.12. Cytokines- communication between immune cells 
Cytokines are soluble proteins produced by both cells of the innate and 
adaptive immunity and play a major role in the host defense. During an infection 
process, cytokines are necessary to stimulate lymphocyte proliferation and 
mediate the activation and conversion into effector cells as well as the 
reconstitution of natural B- and T- cell homeostasis after deletion of pathogens 
[23]. Further important functions include embryogenesis and cell survival. Signal 
transduction within the target cell occurs after cytokine ligation to its surface cell 
receptor and results in alternate gene expression. Cytokines share pleiotropic 
characteristics and redundant effects [36]. The main categorization 
encompasses interleukins, lymphokins and chemokins [23]. Cytokines are often 
produced as precursor proteins and posttranslationally converted into the active 
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form, but regulation occurs also at the RNA transcription level [37]. Actually 
there are five known cytokine groups [23]. 
1.12.1.  Cytokines mainly produced by cells from the innate  
immunity 
The innate immunity demonstrates the first defense against the spreading of 
pathogens. Contact with antigens leads early on to the initiation of cytokine 
transcription and thereafter to the activation of cells from the adaptive immunity.  
 Tumor necrosis factors (TNFs) - 
are important cytokines in the induction of cell apoptosis, reduplication and 
inflammatory reactions [39]. TNFs, earlier also named as cachectin, have further 
important functions in the regulation of the leukocyte movement to the site of 
inflammation [40]. Especially the latter one is caused by TNFα variants. In 
mammalians there are two known isoforms (TNF α and β) [23]. Nuclear factor κB 
(NF- κB) proteins are activated by TNF receptor-associated factors (TRAFs) and 
participate in the TNF transcription [23]. Secretion occurs mostly from neutrophils, 
mast cells and NK cells, but also from activated T cells [39]. TNF exists in two 
variants: the trans membrane bound type forms a heterotrimer and interacts with type 
II TNF receptors (TNFRs) [23]. Interaction of TNF with another receptor variant such 
as type I results in cell apoptose [23]. Both receptor variants are available in nearly 
all cell types. Splitting of TNFR leads to soluble receptor variants and permits the 
binding especially to TNFα cytokines [23, 39]. It is not completely clear if this 
conjugation step supports the TNFα protein conglomeration or inhibits the binding 
mechanism to membrane anchored TNFRs. The exact genetic localization is 
described by Goetz and MacKenzie [39].  
 IL-1β 
IL-1 gene codes for three protein variants, IL-1α and IL-1β and IL-1 receptor 
antagonists (IL-1RA) [88]. Processing of IL-1β by cysteine proteases produces its 
active form [23].  Both cytokine alternatives play important roles in inflammatory 
reactions, whereas IL-1RA inhibits coupling to the IL-1 receptor and reduces 
therefore reactions against inflammatory processes [88].     
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 IL-6- 
manifests itself in both innate and adaptive immunity functions during infection 
processes. Transkription via Jak-STAT transcription factors leads to the production of 
acute phase proteins (innate immunity) as well as to the differentiation of antibody 
producing B cells (adaptive immunity) and proinflammatory cytokines [41].  
 Type I Interferon - 
production is the direct consequence of viral infections. Interferon (IFN) α and β are 
the two main members of the type I interferon group, but IFN-ε,- κ, and –ω belong 
also to it [23, 42]. Its main function relies on the activation of the innate immunity 
especially by upregulation of MHC I proteins on surfaces of APCs [42]. IFNs are 
mainly synthesized by leukocytes, phagocytes and DCs. 
 IL-10 
The immunosuppressive properties of IL-10 are well studied. Beside the inhibition of 
TNF, IFNγ and GM-CSF, reduced levels of IL-1, IL-2, IL-3, IL-6, IL-8 and IL-12 were 
observed [43]. Receptors of IL-10 belong to the type II cytokine receptors [43]. Based 
on the inhibition of cytokines, IL-10 suppresses immune responses against 
inflammatory processes. Dependent on the cell type, IFNγ prevents the synthesis of 
IL-10 or reciprocal [43]. IL-10 synthesis occurs in activated TH2 T helper lymphocytes 
and B cells as well as in cells of the innate immunity such as monocytes, 
macrophages and mast cells [23, 43]. Actively IL-10 is composed of two identical 
monomer subunits and can favor both the formation of IgA, IgG or IgM producing B 
cells as well as the proliferation of leukocytes [43]. High levels of IL-10 are related to 
higher periods of viral latency but also participate in the development of diverse 
diseases [43].   
 IL-12 
Equal to many other cytokines, IL-12 is an important immunoregulatory factor. The 
main producers are APCs activated by intracellular pathogens [44]. IL-12 stimulates 
cells of the innate and adaptive immunity to produce INFγ and has thereby important 
functions in the activation of macrophages [44]. Il-6 and IL-12 cytokines exhibit a high 
redundancy. The structure of IL-12 consists of covalently bound p35 and p40 
heterodimer [44]. The p35 part is identical to that in IL-6 cytokines and the structure 
of p40 exhibits similarities to the extracellular part of the IL-6 receptor [45]. IL-12 
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binds to heterodimeric type I cytokine receptors. The IL-12 cytokine family 
encompasses further IL-23, IL-27 and IL-35 cytokines [45].  
1.12.2. Soluble mediator proteins made by lymphocytes affect innate 
and adaptive immunity 
 IL-2 
T helper cells are the main producers of IL-2 cytokines [50, 51]. IL-2 cytokines, 
categorized into the type I cytokine group, are important key factors in the formation 
and distribution of effector and T regulatory cells [50]. High affinity binding of IL-2 to 
its receptors (IL-2Rs) requires the combination of three main receptor components, 
which are used differently by other immune cells: the α- chain (IL-2Rα, CD25) 
appears on the cell surface of stimulated lymphocytes and binds its cytokine only 
with low affinity, whereas β (CD122) and γ (CD132) chains form a separate complex 
and are mainly distributed on cell surfaces of memory T cells and NK cells [50, 51]. 
The latter two chains are also integrated in other cytokine receptors. According to the 
cell type, IL-2 detection starts-up the PI- kinase, RAS-MAP kinase or JAK STAT 
pathway and results in activation- induced cell death (AICD), cell growth, 
differentiation and survival [50]. 
 IL-4- 
is mainly produced by the TH2 subset of CD4
+ T cells [53]. More sources are 
basophile granulocytes and mast cells [53]. Hematopoietic cells, endo- and epithelial 
tissues, fibroblasts and hepatocytes express type I receptors for the IL-4 cytokine 
detection [53]. The main consequences of its detection concern the switch of 
immunoglobulins into IgE and IgG4 isotype and protect therefore against extracellular 
parasites [53]. Il-4 advances also the development of the TH2 subcategory of T helper 
cells, the secretion of TH2 cytokines and the increased expression of MHC II proteins 
on cell surfaces [52].  
 IL-13- 
cytokines cause high MHC class II expression on surfaces of monocytes and B cells 
and additionally exhibit anti-inflammatory properties by reducing the cytokine 
secretion of various cell types [54]. Furthermore IL-13 supports the IgE production 
during class switch processes in B cells and controls the cell mediated immunity 
against intracellular bacteria [54].  
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 IL-17- 
cytokine family contains 6 members (IL-17A, IL17B, IL-17C, IL-17D, IL-17E and IL-
17F) [55, 56]. T helper cells stimulated by IL-15 or IL-23 are the major producers of 
IL-17 cytokines. The activation of T cells via TCR is not necessary for the secretion of 
some members of the IL-17 cytokine family [55]. All IL-17 cytokines achieve 
important pro- inflammatory functions. The first discovered IL-17 family member, IL-
17A, initiates the production of cytokines by different cell types mainly from the innate 
immunity whereas IL-17E is known to activate the production of TH2 cytokines and 
multiplication of eosinophils [56].  
 IL-22- 
Secretion occurs by activated DCs and T- cells and affects mainly epithelial cells to 
emit pro-inflammatory and anti- microbial products [57]. IL-22 cytokines belong to the 
IL-10 superfamily and bind to a complex consisting of IL-10 and IL-22 components 
for the complete effector function [57].   
 IFN-γ- 
also referred to as type II interferon- are produced by both cells of the innate and the 
adaptive immunity [23]. IFN-γ plays an important part in early phases of the immune 
defense and is highly produced by NK cells, CD8+ lymphocytes and TH1 subgroup of 
T helper cells [58]. IL-4, IL-10 and TGFβ clearly reduce type II IFN secretion. The 
biggest effects of IFN-γ relies in the activation of NK cells and macrophages as well 
as in the enhanced appearance of MHC surface molecules [58], T helper cell 
differentiation into TH1 subgroup and B cell switching into the IgG isotype [23].  
 TGF-β 
The immmunoregulatory properties of TGF-β affect lymphocytes, Natural killer cells 
(NK cells), DCs, macrophages, mast cells as well as granulocytes [60]. Actually there 
are three known mammalian TGF- β cytokines (TGF- β 1-3) and each of them is 
produced in nearly all leukocytes [61]. Thymocyte proliferation and differentiation plus 
T cell survival and expansion is strongly influenced by TGF- β polypeptides. This 
effect holds equally for all T cell subgroups such as regulatory T cells (Tregs), 
cytotoxic T cells and T helper cells [60, 61].  TGF- β influence on B cell development 
is comparable to the inhibitory consequences on T cells and results in non- activation 
and apoptosis of immature or resting B cells. In addition to the apoptotic effects, 
TGF- β blockades the B cell receptor (BCR) isotype class switch except for IgA 
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heavy chain variants [61]. It has also been reported that TGF- β inhibit the 
appearance of TfRs on B cell surfaces [61]. Inhibitory effects are also noticeable for 
NK cells (effector function and cytokine production), macrophages (phagocytosis and 
antigen presentation) and neutrophil granulocytes (movement across the 
endothelium by reducing adhesion molecules) [60]. Pro- inflammatory regulation by 
the action of TGF- β is observable for macrophages, mast cells and monocytes 
(upregulation of attachment molecules on cell surfaces) [60]. 
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2. AIM OF THE STUDY 
The transferrin receptor (TfR) is important for import of transferrin-iron 
complexes into cells and is known as a critical regulator of the function of 
immune cells. Dendritic cells (DCs) are prominent antigen presenting cells and 
are key regulators of adaptive as well as innate immune responses. Yet, little is 
known about the functional role of TfR (CD71) on DCs. Therefore, the aim of 
this study was to analyze the impact of CD71 on differentiation and maturation 
of human, monocyte-derived DCs with four monoclonal antibodies (mAbs) 
directed against CD71, which have been generated in our laboratory (mAb VIP-
1, 5-528, 15-221 and 13-344 ), as demonstrated in Figure 5. 
 
 
Figure 5: Analysis and characterization of 4 mAbs that recognize epitopes on the 
extracellular part of the human TfR (CD71).  
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3. MATERIALS AND METHODS 
 
 
3.1. Antibodies 
 
Specifity Clone Isotype species Source 
T cell stimulation 
CD3 OKT 3 IgG2a mouse Jansen-Cilag, Vienna 
CD28 15E8 IgG1 mouse Caltag Laboratories, 
Burlingame, CA 
CD63 CD63-
11C9 
IgG3 mouse Otto Majdic,IFI, Vienna 
Straining and Treatment 
Calf intestine alkaline 
phosphatase 
VIAP-2D5 IgG1 mouse Otto Majdic,IFIy, Vienna 
CD1a VIT6b IgG1 mouse Otto Majdic, IFI, Vienna 
CD3 UCHT1 IgG1 mouse Otto Majdic, IFI, Vienna 
CD4 VIT4 IgG2a mouse Otto Majdic, IFI, Vienna 
CD8 LM2 IgG1 mouse ATCC, Rockville, 
Tenesse 
CD14 VIM13 IgM mouse Otto Majdic, IFI, Vienna 
CD40 G28-4 IgG1 mouse ATCC, Rockville, 
Tenesse 
CD45 VIT200 IgG2a mouse Otto Majdic, IFI, Vienna 
CD45 8-301 IgG1 mouse Otto Majdic, IFI, Vienna 
CD69 Leu-23 IgG1 mouse Becton Dickinson, Palo 
Alto, CA 
CD71 13-344 IgG1 mouse Otto Majdic, IFI, Vienna 
CD71 5-528 IgG1 mouse Otto Majdic, IFI, Vienna 
CD71 VIP-1 IgG1 mouse Otto Majdic, IFI, Vienna 
CD71 15-221 IgG2b mouse Otto Majdic, IFI, Vienna 
CD80 7-480 IgG1 mouse Otto Majdic, IFI, Vienna 
CD83 HB15 IgG2b mouse Caltag Laboratories, 
Burlingame, CA 
CD86 BU63 IgG1 mouse Caltag Laboratories, 
Burlingame, CA 
CD169 7-239 IgG1 mouse Otto Majdic, IFI, Vienna 
CD169 7-526 IgG1 mouse Otto Majdic, IFI, Vienna 
CD274 1-550 IgG1 mouse Otto Majdic, IFI, Vienna 
CD274 5-496 IgG1 mouse Otto Majdic, IFI, Vienna 
B7-H1 5-272 IgG1 mouse Otto Majdic, IFI, Vienna 
B7-H3 7-517 IgG1 mouse Otto Majdic, IFI, Vienna 
HLA-class I  W6/32 IgG2a mouse ATCC, Rockville, 
Tennesse 
HLA- DR  class II L243 IgG2a mouse Otto Majdic, IFI, Vienna 
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3.2. Buffers, chemicals and media 
List of reagents and chemicals 
Beriglobin 
20 mg/ml (in 
PBS/BSA) 
Aventis Behring, 
Vienna, Austria 
GM-CSF 130 µg/ml 
Fermentas, Burlington, 
Canada 
IL-4 100 U/ml 
Novartis Research 
Institute, Vienna 
methyl-3H-thymdine 1m Ci/ml 
Perkin Elmer, 
Waltham, MA 
Ionomycin 200 nM Sigma-Aldrich 
L-Glutamin 2 mM Sigma-Aldrich 
LPS, serotype O127-B8, 
E.coli 
1µg/ml Sigma-Aldrich 
Penicillin 100 µg/ml Sigma-Aldrich 
Peptidoglycan  10µg/ml Sigma-Aldrich 
PMA 200 nM Sigma-Aldrich 
Poly I:C 20 mg/ml  Sigma-Aldrich 
Streptomcyin 100 µg/ml Sigma-Aldrich 
zymosan A, S. cerevisiae 30 µg/ml Sigma-Aldrich 
 
 Heparin Medium: 
500 ml RPMI 1640 medium. Add 100 U/ml penicillin + 100  µg/ml streptamycin 
and 2 mM L-glutamine (stored at -20°C). Add 10 U/ml Heparin (stock: 5000 
U/ml, Baxter, Vienna) 
 Freezing medium: 
RPMI1640 supplemented with 25% FCS and 10% DMSO  
 MACS- buffer (stored at 4°C):  
1000 ml 1x PBS def. + 25 ml Human Serum Albumin (stock: 20%, Centeon, 
Vienna) + 10 ml EDTA (stock: 0,5 M); sterile filtration 
 10x PBS stock solution: 
5,8 g KH2PO4 
16,6 g Na2HPO42H2O 
72 g NaCl 
Dissolve in aquabidest (=ddH2O), fill up to 10 litres and adjust to pH 7,2 
 
 
 PBS/BSA stock solution (20%): 
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100 g BSA 
10 g NaN3 
Dissolve in 500 ml PBS buffer. For the PBS/BSA wash buffer, prepare a 1:20 
dilution with PBS buffer. 
 0,5M Tris-HCL pH 6.8: 
6 g Tris (Biorad, Hercules, CA) were dissolved in ddH2O and pH was adjusted 
to 6.8 with 6 N HCL. Then the solution was brought to 100 ml with ddH20.  
PBST (PBST 0,5%) 
PBS with 0,5% Tween 20 
 1,5M Tris-HCL pH 8.8: 
18,2 g Tris (Biorad, Hercules, CA) were dissolved in ddH2O and pH was 
adjusted to 8.8 with 6 N HCL. Then the solution was brought to 100 ml with 
ddH2O.  
 10% n-dodecylsulphate sodium salt, 
SDS (Sigma, St. Louis, MO): 5g were dissolved in 50 ml ddH2O and stored at 
room temperature.  
 10% Ammoniumpersulfat, APS (sigma, ST. Louis, MO): 100 mg/ml  
 Running buffer (4x) 
Tris 12 g 
SDS 4 g 
Glycin 57,6 g 
Fill up to 100 ml with ddH2O 
 Blotting buffer 
250 ml of 4x running buffer 
200 ml methanol 
ad ddH2O= to 1000 ml  
 Dry milk solution 
5% dry milk powder dissolved in PBST buffer 
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3.3. cultivation of cell lines 
Human tumor cell lines 
Cell line Cell type Immunology Source 
K562 
Human chronic myeloid 
leukemia in blast crisis 
(erythriod, no MHCs) 
CD3-, CD13+, CD19-, 
CD34-, CD41(+), CD42+, 
CD45+, CD71+, GlyA(+) 
ATCC 
(American 
Type 
Culture 
Collection) 
B and T cell lines 
DAUDI 
Human Burkitt`s 
lymphoma (EBV+) 
CD3-, Cd10+, CD13(+), 
CD19+, CD20+, CD34-, 
CD37+, HLA-DR+ 
ATCC 
KM-H2 
Human Hodgkin`s 
lymphoma 
CD3-, CD13(+), CD14(+), 
CD15+, CD19-, CD21+, 
CD25-, CD30+, HLA-DR+ 
DMSZ 
JURKAT Human T cell leukemia 
CD2+, CD3+, CD4+, CD5+, 
CD6+,CD7+, CD8-, CD13-, 
CD19-, CD34+, TCRα/β+, 
TCRγδ- 
ATCC 
 
Murine tumor cell lines 
Murine AKR, BW 5417 as well as BW cells expressing the human CD71 were 
kindly provided by Dr. Peter Steinberger (Institute of Immunology, Medical 
University of Vienna).  
 
For cell culture of monocytes, dendritic cells and both human and murine cell 
lines RPMI1640 (NBK, Novartis Research Institute, Vienna) supplemented with 
10% fetal calf serum (HyClone, Utal), 2 mM L-glutamine, 100 U/ml penicillin and 
100 µg/ml strepamycin was used. Cells were cultured at 37°C with 5% CO2. 
 
3.4. PBMNC extraction 
Peripheral blood mononuclear cells (PBMNCs) were separated from fresh blood 
samples (Buffy coats, Red Cross Vienna) of healthy donors. Blood was diluted 
1:2 with Heparin medium (Gibco Ltd., Paisley, Scotland). The diluted blood was 
then overlaid above 15 ml Ficoll-Paque plus (Axis- Shield PoC AS, Oslo 
Norway) to a final volume of 50 ml. For density gradient centrifugation the tubes 
were centrifuged at 900 g for 30 minutes at 25°C without braking. In the FIcoll 
gradient blood cells are separated due to their different density. The pellet 
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contains mainly erythrocytes and leukocytes, whereas the white interphase 
contains PBMNCs consisting of lymphocytes and monocytes and the upper 
phase contains serum. PBMNCs were then collected into fresh tubes and 
washed twice with MACS buffer. 
 
3.5. Monocyte and T cell isolation 
For monocytes up to 1 x 109 PBMNCs were incubated with 15 µg/ml of 
biotinylated (CD14 (VIM13, MEM18). Therefore PBMNCs were resuspended in 
750 µl MACS buffer and incubated with 250 µl streptavidin MicroBeads (Miltenyi 
Biotec, Bergisch Gladbach, Germany) were added to the suspension and 
incubated for 15 min at 4°C. In the meantime a CS column (Miltenyi Biotec) that 
can be loaded with a maximum of 109 cells, was placed onto a VarioMACS 
apparaturs and equilibrated with 40 ml MACS buffer. Monocytes were positively 
enriched. The PBMNCs incubated with the CD14 mAb and the streptavidin 
MicroBeads were loaded onto the CS column. CD14+ monocytes remained in 
the column, CD14- cells were washed out with 40 ml MACS buffer. The flow 
through was collected as monocyte negative fraction containing T cells, B cells 
and NK cells (fraction 1). The column was removed from the magnetic field and 
the MACS buffer was added in 10 ml portions alternating through the side 
syringe or loaded on the top of the column. After each addition step the column 
was put back into the magnet field and about 10 ml were allowed to run 
through. These steps were repeated until a volume of 50 ml had passed 
through (fraction 2). For monocyte collection the column was removed from the 
magnet field and the liquid was taken off through the lateral valve using a 
syringe. These steps were repeated until the collected volume came to 40 ml 
(fraction 3). The third fraction was centrifuged for 5`at 900 g, resuspended and 
the number of monocytes was determined. The purity (> 95%) of monocytes 
was controlled by immunofluorescence analysis. Double-staining with directly 
labeled antibodies using CD4-PE (CD3-FITC, CD8-PE/CD3-FITC, CD19-
PE/CD3-FITC, CD56-PE/CD3-FITC, HLA-DR-PE/CD3-FITC, CD14-PE/HLA-
DR-FITC.  
To isolate T cells from up to 1x109 PBMNCs the MACS technique was used. T 
cells were isolated by collecting the flow through of PBMNCs depleted by using 
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different mAbs at a concentration of 10 µg/ml containing CD14 (MEM18) for 
collecting monocytes, CD16 (3G8) for binding granulocytes and NK cells, CD19 
for B cells (BU 12) and CD33 (4D3) for monocytes, thrombocytes and myeloid 
progenitors (negative selection). Freshly isolated PBMNCs were resuspended 
in 750 µl MACS buffer and incubated with 250 µl biotinylated antibodies for 15 
min at 4°C. To remove unbound antibodies the cells were washed twice with 
MACS buffer and again resuspended in 750 µl buffer. Then 250 µl streptavidin 
MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) were added to the 
suspension and incubated for 15 min at 4°C. In the meantime a CD column 
(Miltenyi Biotec) that can be loaded with a maximum of 1*109 cells, was placed 
onto a VarioMACS apparatus and equilibrated with 40 ml MACS buffer. 
PBMNCs were loaded onto the column, T cells were eluted and washed until a 
volume of 50 ml was reached. The collected T cells were centrifuged for 5`at 
900g, resuspended and the number of cells was determined.   
 
3.6. Freezing and thawing of cells 
 
3.6.1. Freezing of cells 
Mammalian cells can be stored in liquid nitrogen for prolonged periods of time 
with minimal loss of viability in a subsequent cell culture. For that purpose, cells 
were centrifuged, counted, resuspended in freezing medium (RPMI1640 
supplemented with 25% FCS and 10% DMSO and adjusted to a cell number 
ranging from 107 – 5 x 107 cells/ml. 1 ml aliquots were filled into cryotubes 
(Nalgen Nunc International, Roskilde, Denmark) and kept overnight at -80°C in 
a freezing box filled with isopropanol before being transferred to liquid nitrogen.  
3.6.2. Thawing of cells 
Cryotubes were thawed in lukewarm water bath. To avoid overheating we left a 
rest frozen and put the tube on ice for 10 min. Afterwards the cells were 
transferred to a 15 ml tube and droplets of supplemented cell culture medium 
(RPMI1640 plus 10% FCS (Sigma-Aldrich), L-glutamine, penicillin, 
streptomycin) were added in an interval of 1 min: Starting with 3 drops, 6 drops 
after the first minute, 12 drops in the second minute etc. up to 48 drops. The 
cells were washed twice with RPMI1640, counted and cultured in medium.  
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3.7. Generation of dendritic cells derived from monocytes 
DCs were generated by culturing purified monocytes for 6 days with a 
combination of 50 ng/ml GM-CSF and 100 U/ml IL-4 in RPMI1640 
supplemented with 10% characterized FCS, 2 mM L-glutamine, 100 U/ml 
penicillin, 100 µg/ml streptomycin (sigma-Aldrich). Maturation of DCs was 
initiated by adding 1 µg/ml LPS for 24 hours.  
 
3.8. Mixed leukocyte reaction (MLR) 
In an allo – MLR lymphocytes from a potential donor are mixed with stimulator 
cells from a potential recipient, i.e. APCs like DCs. If the two cell populations 
are not compatible in their MHC, which means they are allogeneic, proliferation 
of T cells occurs. 5*105 DCs pretreated with 5 µg/ml CD71 mAbs for 48 hours 
were cultivated with 1*105 responder T cells in RPMI1640 (10% FCS (Sigma-
Aldrich), L-glutamine, penicillin, streptomycin) for 5 days on a final volume of 
250 µl under standardized cell culture conditions (37°C, 5% CO2, humidified 
atmosphere). Each experiment was performed in triplicate in 96-well plates 
(Costar, Sigma Aldrich). On day five 25 µl of 1:20 diluted methyl- [3]thymidine (1 
µCi/well) (Perkin Elmer, Waltham, MA) and after adding 25 µl of Microscint 
scintillation mix (Packard, Meriden, Connecticut) in each well radioactive 
emissions quantified on a Packard microplate scintillation counter.  
 
3.9. T cell proliferation assay 
96-well plates (Costar, Sigma Aldrich) were coated with CD3 (OKT3), 
CD3/CD28 (OKT3/15E3) and CD3/CD63 (OKT3/11C9) mAbs at a concentration 
of 2 µg/ml. The plates were coated with a volume of 25 µl of antibody-solution 
overnight at 4°C or for about 2 hours at 37°C. Then the antibody solution was 
removed and the plates were washed twice with PBS. 1 x 105 T cells in 
RPMI1640 medium supplemented with FCS were added into each well and 
incubated in combination with 5 µg/ml CD71 mAbs. Proliferation of T cells was 
monitored by measuring (methyl—H)-TdR (Perkin Elmer, Waltham, MA) 
incorporation on day 4 of the culture. Cells were harvested 18 hours later, and 
radioactivity was determined on a microplate scintillation counter (Perkin Elmer, 
Wellesley, MA). Assays were performed in triplicate.   
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3.10. Cell analysis via flow cytometry 
In a flow cytometer, single cells move past the excitation source and the light 
hitting the cells is either scattered or absorbed and then re-emitted 
(fluorescence). This scattered or re- emitted light is collected by a detector. 
Scattered light is the consequence of a light beam making contact with a cell, 
resulting in either reflected or refracted light reaching the detector. The pattern 
of light scattering is dependent on cell size and shape, giving relative measures 
of these cellular characteristics as cells flow through the beam. This can be 
quite useful, as cells can be sorted on the basis of size or shape into different 
collection tubes using a technique called electrostatic deflection which employs 
charged plates to change the path of the cell. Fluorescence-based detection 
depends on the absorption of light by the cell and the subsequent re-emission 
of this light at a different wave-length. Flow cytomters make use of this 
technology by employing filters to block the original light source from reaching 
the detector, while the fluorescent emission is allowed through for detection, 
which allows only a very low background of stray light to reach a detector. In 
flow cytometry experiments, fluorescence is often achieved by the deliberate 
labeling of a cellular component using a fluorescent marker covalently bound to 
an antibody, usually a type of dye. These dyes fluoresce only when light of the 
appropriate wavelength (specified by the frequency of the laser) hits them, 
causing the emission of secondary light at a different wavelength. Detection of 
the second wavelength is used as a measure of the presence of the antigen 
recognized by the antibody on the cell. 
 
3.11. Membrane staining with unconjugated mAbs 
Unspecific binding of mAbs to Fcγ-receptors was blocked by incubation of cells 
with human immunoglobin Beriglobin (Aventis Behring GmbH, Vienna). As 
isotype control VIAP, a calf intestine alkaline phosphatase- specific antibody 
was applied. For secondary labeling Oregon Green- conjugated goat anti- 
mouse antibody was used.  
 PBS/BSA: 1xPBS + 1% BSA 
 Beriglobin (final concentration 20 mg/ml) diluted 1:8 in PBS/BSA (1% v/v 
BSA) (Aventis Behring GmbH, Vienna) 
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 Primary antibody: 20 µg/ml 
 Secondary antibody: Oregon Green-conjugated goat-anti-mouse IgG 20 
µg/ml in PBS/BSA (Molecular Probes; Eugene, Oregon) 
First the cell suspension (5 x 105 / assay) was centrifuged for 5 minutes at 300 
g and the pellet was resuspended with 50 µl Beriglobin/assay and kept 10 
minutes on ice. Then 20 µl of the antibody were prepared in Mirconic-tubes and 
50 µl of the cell suspension was added, mixed and incubated 30 minutes at 
4°C. Each assay was washed twice with PBS/BSA (resuspended in PBS/BSA, 
centrifuged (5 min at 300g), the supernatant was discarded). 20 µl Oregon 
Green were added to the cells, and again incubated for 30 min at 4°C. Each 
assay was washed twice with PBS/BSA and the cells were resuspended in 50 
µl FACS fluid (Becton Dickinson, Franklin Lakes, NJ). The tubes were kept on 
ice until they were analyzed by flow cytometry using a FACScalibur Flow 
cytometer (Becton Dickinson, Palo Alto, CA).   
 
3.12. Cell surface staining with conjugated mAbs 
The cell suspension (5 x 105 / assay) was centrifuged for 5 minutes at 300 g 
and the pellet was resuspended with 50 µl Beriglobin/ well and kept 10 minutes 
on ice. 20 µl of the respective antibody was prepared in Micronic-tubes and 50 
µl of the cell suspension was added, mixed and incubated for 30 minutes at 
4°C. Each assay was washed twice with PBS/BSA (resuspended in PBS/BSA, 
centrifuged (5 min at 300 g), the supernatant was discarded) and the cells were 
resuspended in 50 µl FACS fluid (Becton Dickinson, Franklin Lakes, NJ). The 
tubes were kept on ice until they were analyzed by flow-cytometry.  
 
3.13. Epitop mapping 
Epitop mapping was applied to examine whether different mAbs have 
overlapping binding sites. For this experiment we used strongly proliferating 
KM-H2 cells (Human Hodgkin`s lymphoma). The cells (5 x 105 KM-H2 
cells/assay) were spun down (5 min at 1750 rpm). The pellet was resuspend 
with 50 µl Beriglobin/assay and kept 10 min on ice. 25 µl of an unlabeled 
antibody (20 µg/ml) were prepared in Micronic tubes and 50 µl of the cell 
suspension was added, mixed and incubated 30 min at 4°C. 20 µl of a 
MATERIALS AND METHODS 
 
48 
 
conjugated antibody were added to the cells, mixed and incubated 30 min at 
4°C. The tubes were kept in ice until they were analyzed by flow cytometry.   
 
3.14. Protein extraction and detection 
 
3.14.1. Protein sample preparation 
KM-H2 and K562 cells were cultured for 4 days with PMA and ionomycinein 
RPMI1640 + 10% FCS or without stimulation. Subsequently, cells were 
harvested, washed 2 times with ice cold PBS and solubilized in lysis buffer (20 
nM NaH2PO4; 2 mM ETA; 2 mM EGTA; 2 mM NaF, pH8,4) containing 1% 
IGEPAL CA-630 (Sigma) and supplemented with Complete Protease Inhibitor 
cocktail (Roche Diagnostics, Mannheim, Germany) for 20 minutes on ice. 
Lysates were spun down for 20 min at 13.000 rpm at 4°C and immediately 
frozen.  
3.14.2. Immunoprecipitation 
For immunoprecipitation 10 µg/ml anti CD71 mAbs (CD71 mAbs VIP-1, 15-221, 
5-528, 13-344 ) were loaded onto 7x108 sheep anti-mouse IgG Dynabeads (M-
280, Streptavidin) with 2,8 µm diameter according to the manufacturer`s 
instructions. After washing twice in PBS, the beads were incubated with cell 
lysate of cell- culture supernatant for 48 h at 4°C. Subsequently the beads were 
washed twice and bound protein was eluted into reducing sample buffer 
(Biorad, Richmond, CA) by boiling for 5 min and centrifugation (20200 rcf; 5 
min). Samples were analyzed using gel electrophoresis combined to silver 
staining and western blotting.  
3.14.3. Gel electrophoresis 
SDS Polyacrylamide Electrophoresis is a useful system to separate proteins 
according to their size. SDS is a powerful detergent, which has a very 
hydrophobic end (the lipid like dodecyl part) and highly charged part (the sulfate 
group). The dodecyl part interacts with hydrophobic amino acids in proteins. 
Since the 3D structure of most proteins depends on interactions between 
hydrophobic amino acids in their core, the detergent destroys 3D structures, 
transforming what were globular proteins into linear molecules now coated with 
negatively charged SDS groups masking the actual charge of proteins. After 
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boiling in SDS proteins therefore become elongated with negative charges 
arrayed along their length, so they will move towards a positive electrode more 
or less fast according to their respective size. The reason why β- 
mercaptoethanol is usually included in the sample buffer is to cleave disulfide 
bonds within or between molecules, allowing molecules to adopt an extended 
monomeric form. Lysates were 1:2 mixed with reducing Laemmli sample buffer 
containing 5% β- mercaptoethanol (Biorad, Richmond, CA) and boiled at 95°C 
for 5 min. Proteins were separated by electrophoresis on 10% SDS- 
polyacrylamide gels using the Hoefer Mighty Small system (Amersham, Little 
Chalfont, UK). As running buffer 25 mM Trise base, 192 mM glycine, 0,1% SDS 
was used.  
Reagent 10% Seperation gel 2% Stacking gel 
30% Acrylamide- 
Solution 
4 ml 440 µl 
H2O 4,8 ml 2 ml 
1,5 M Tris HCL pH 
8,8 
3 ml -- 
0,5 M Tris HCL pH 
6,8 
-- 840 µl 
10 % SDS-solution 100 µl 35 µl 
Ammoniumpersulfate 
(10 %) 
100 µl 35 µl 
TEMED 8 µl 4 µl 
 
As protein standard SeeBlue Plus 2 prestained marker (Invitrogen) was used.  
3.14.4. Western blot  
Western blotting allows to determine, with a specific primary antibody, the 
relative amounts of the proteins present in different samples. Separated 
samples are transferred to a membrane for detection. The membrane is 
incubated with a generic protein to bind to any remaining sticky places on the 
membrane and therefore blocking unspecific antibody adherence on the 
membrane itself. A secondary antibody is then added to the solution which 
recognizes the primary antibody to find locations where the primary antibody 
has bound.  
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Proteins that were separated by SDS-Page were blotted onto Immobilon-P 
PVDF membranes (Millipore, Billerica, MA) using the Hoefer Semiphor TE77 
system (Amersham, Buckinghamshire, UK) for 1 hour at 15 V. As blotting buffer 
25 mM Tris base, 192 mM glycine, 5% Methanol was used. Membranes were 
blocked with 5% dry milk / 0,1% Tween20 and incubated with primary antibody 
(1 µg/ml) in the same solution (7 rpm, overnight, 4°C). After washing (5 x 5 min) 
with 1% PBS / Tween20, membranes were incubated with the secondary HRP 
conjugated anti-mouse-Ig antibody dilution (1:10000 in blocking buffer) in 50 ml 
falcon tube (7 rpm, 1 hour, 25°C or overnight at 4°C). Enhanced 
chemiluminescence (ECL) was used for the detection of proteins. Therefore 
membranes were incubated with ECL solution (20 ml 1 M tris pH 8.8, 500 µl p-
coumaric acid 340 mg in 26 ml DMSO, 1 ml Luminol 2.26g in 51 ml DMSO, 180 
ml aqua dest.), placed between two plastic overhead sheets, covered with a 
Kodak XAR film (Sigma-Aldrich, ST. Louise, MO) and placed into a film 
cassette.  
Sample buffer 
Laemmli sample buffer (Biorad, Hercules, CA), before use 5-10 % β- 
mercaptoethanol was added 
Protein standard 
Benchmark Prestained Protein Ladder from Invitrogen, Carlsbaden, CA 
3.14.5. Silver staining 
50 ml methanol, 12,5 ml acetate and 2,5 ml reagent A were mixed and brought 
with ddH2O to 100 ml (solution 1). Gels were shaken in that solution for 30 min. 
After discarding of solution, 10 ml methanol and 12,5 ml acetate were brought 
with ddH2O to 200 ml (solution 2). Gels were shaken for 15 min, then the 
solution was changed to solution 2 and gels were shaken for another 15 min. 
The gels were washed for twice for 5 min in ddH2O. For enhancement 25 ml 
reagent B and 50 ml ddH2O were mixed and gels were shaken for 10 min in that 
solution. The gels were washed again in ddH2O.  For staining 2,5 ml reagent C 
were brought to 100 ml with ddH2O and gels were incubated in this solution for 
10 min. After the last washing step with ddH2O (1 min), 1,5 g of reagent D were 
dissolved in ddH2O,  1,25 ml reagent B were added, brought to 50 ml and 
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incubated for 10-15 min. The reaction was stopped by immersing the gel into 
reagent F.  
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4. Results 
 
 
4.1. MAbs VIP-1, 15-221, 5-528 and 13-344 recognize human TfR 
proteins (CD71) 
 
It is common that the high proliferation rate of lymphoma cells is dependent on 
an efficient iron uptake mechanism. Therefore we verified the binding of our 
tested CD71 mAbs using a murine BW lymphoma cell line expressing human 
TfR proteins. Each mAb recognizes only particular sequence areas of the 
surface proteins and ensures the high specificity of the staining. Depending on 
the number of expressed surface proteins, the fluorescence intensity increases 
or decreases. In 1989, Knapp et al [74] described mAb VIP-1 to recognize 
epitopes of the human TfR. Therefore mAb VIP-1 was used as a positive control 
antibody to verify the detection of TfR surface proteins.  
 
Figure 6: A murine cell line (BW) has been transfected to express human TfRs on the cell 
surface. The mAb VIP-1 serves as control antibody for the detection of the human TfR proteins. 
All antibodies have been used in the fluorochrom conjugated form. Black lines demonstrate the 
linkage of diverse CD71 mAbs (names within the respective boxes); gray and spotted lines 
show the negative control. One representative experiment of three independent experiments is 
shown.  
 
As shown in Figure 6, mAb 15-221, 5-528 as well as mAb 13-344 show similarly 
increased levels of fluorescence intensity compared to mAb VIP-1. These data 
leads to the validation that all of our tested antibodies recognize the same 
surface proteins. 
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4.2. mAbs bind to Tf surface receptors (CD71) on various cell 
lines 
Since all of the tested antibodies appear to bind to human TfRs expressed on 
murine cells, we were interested in the binding capacity to other cell lines 
exhibiting a high number of CD71 molecules. Based on the fact that growing 
and fast proliferating cells need iron to a higher degree, we analysed human 
lymphoid leukemia cells for the surface staining of CD71 receptors. The species 
specificity of our mAbs was tested by the following staining of murine and insect 
cell lines.  
4.2.1. MAbs VIP-1, 15-221, 5-528 and 13-344 react with  
 human B- and T- cell leukemia cells 
Daudi B cell lymphoma belongs to the major group of non-Hodgkin`s- 
lymphoma. Already in 1985 Besancon et al. [75] used this cell type to 
demonstrate that treatment of Daudi cells with INFα lead to the downregulation 
of Tf surface receptors. The publishing of further TfR inhibition data supported 
the theory of iron requirement for the functionality of enzymes and therefore the 
importance of highly expressed TfRs on cell surfaces of fast proliferating cells. 
All four tested antibodies bound with high affinity to the surface of the Daudi cell 
line (Figure 7).  
 
Figure 7: Daudi B lymphoma cell line was tested for the expression of TfR proteins via 
the conjugated anti- CD71 mAb VIP-1. The high expression of TfRs (black line) reflects the 
increased necessity of iron during the DNA syntheses process. Protein surface staining 
occurred via direct conjugated (FITC or PE) mAbs. Antibodies 15-221, 5-528 and 13-344 show 
RESULTS 
 
54 
 
a similar strong binding pattern compared to the CD71 control antibody VIP-1. One 
representative experiment of two independent experiments is shown. 
 
We used furthermore a second type of B cell lymphoma to test the binding 
affinity of CD71 mAbs on human lymphocytes. The Raji cell line had originally 
been taken from a Burkitt`s lymphoma patient [76] and exhibits a high division 
rate under standard cultivation conditions. Simliar to the previously shown non- 
Hodgkin B cell lymphoma (Figure 8), all tested mAbs interact with protein areas 
on the surface of the immortalized B cell line. The high fluorescence level 
correlates directly with the number of bound antibodies and indicates therefore 
an increased appearance of surface proteins. CD71 mAb VIP-1 bind to a TfR 
epitope in a similarly intensity compared to the other three mAbs and agree with 
the data from the staining of the Daudi cell type (Figure 8).  
 
Figure 8: Raji, a Burkitt`s lymphoma cell line including Epstein- Barr virus sequences, 
was used to analyze the expression of CD71 receptors.  Comparable to Daudi cells (Figure 
8), Raji lymphomas grew under standard conditions and were subsequently stained for TfR 
expression. For the staining process we used identical mAbs as already used for the staining of 
Daudi cells. One representative experiment of two independent experiments is shown. 
 
Based on the results of Daudi and Raji cell stainings, we analyzed the CD71 
expression on surfaces of non- B cell lymphoma. K562 are immortalized cells 
derived from an acute myeloid leukemia patient. Jurkat lymphoma, a further 
analyzed cell line has been isolated in the 1970`s from a T cell lymphoma 
patient and is known for the high IL-2 secretion after treatment with mitogen 
stimuli. Jurkat cells are an important tool to analyze T cell receptor signaling 
and processes in correlation with cytokine production [77]. Both the human 
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erythroleukemia cell line K562 and Jurkat cells exhibit an elevated number of 
TfR surface proteins in which we observed a much stronger CD71 expression 
on Jurkat lymphoma. Beside the increased fluorescence signal for  CD71 mAb 
VIP-1, mAbs 15-221, 5-528 and 13-344 manifest again comparable strong 
affinities for receptor recognition at both cell types (Figure 10 and 11).  
 
Figure 9: Antigen recognition of conjugated mAbs VIP-1, 15-221, 5-528 and 13-344 at the 
cell surface of K562 cells. Cultivation of the human erythroleukemia cell line was established 
in an identical manner as already described. One representative experiment of two independent 
experiments is shown. 
 
Figure 10: Human CD4+ Jurkat T cell lymphoma cells were cultivated in the same way 
like other cells described before and analyzed concerning the CD71 surface protein 
expression. The number of epitope linked antibodies is reflected by the increased fluorescence 
intensity (black graphs) detected via flow cytometry. The gray dotted lines show the isotype 
control.  
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4.2.2. mAb 13-344 cross-reacts with murine TfR proteins 
In order to define the species specificity of mentioned mAbs, we performed 
staining approaches for murine cell lines in the same way as described 
previously for human lymphoma. The binding affinity of mAb VIP-1, 15-221, 5-
528 and 13-344 to murine CD71 antigen was investigated on a AKR mice strain 
derived T cell lymphoma as well as on murine B cell lymphoma cells.   
 
Figure 11:  Analysis of the correlation between the four CD71 mAbs and murine T cell 
lymphoma extracted from AKR mice. Murine cells grew under identical conditions as 
described for human cells. In contrary to human cell lines, only mAb 13-344 binds the murine 
TfR. One representative experiment of three independent experiments is shown. 
 
 
Figure 12: BW 1C8, a B cell lymphoma in mice, was used to determine the binding affinity 
of 4 mAbs to the TfR proteins on the cell surface of murine cells. For the receipt of the 
fluorescence signal the same staining procedure has been followed as described earlier for 
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AKR cells and human lymphoma. One representative experiment of two independent 
experiments is shown.  
 
Formerly studies on mAb VIP-1demonstrated a binding specificity exclusively 
for TfR proteins on surfaces of human cells [78-80]. This result is confirmed by 
staining experiments of murine CD71 surface proteins (Figure 11 and 12). In the 
same way as mAb VIP-1 but contrary to stainings of human cell lines presented 
above, neither mAb 15-221 nor mAb 5-528 shows any reactivity with murine 
TfR proteins. However, a higher binding activity is clearly visible for mAb 13-344 
in both murine T and B cell lymphoma (Figure 11 and 12).  
4.2.2.1. Activated murine primary B and T lymphocytes show also 
an upregulation of TfRs.  
Similar to lymph nodes, the mammalian spleen provides important functions in 
blood filtration, antigen detection and renewing of erythrocytes. The white pulp 
of the spleen mostly contains a collection of various monocytes, macrophages, 
B and T lymphocyte populations [23]. Immune cells inside the spleen are also 
described as splenocytes. Based on the fact that mAb 13-344 recognized TfR 
epitopes on fast proliferating murine B and T lymphoma cells, we analyzed the 
surface receptor expression pattern on non- leukemia cells. Freshly isolated 
murine splenocytes are barely recognized by any of our tested antibodies 
(Figure 13). However, activation of these immune cells via PMA / Ionomycin 
causes an increased iron requirement and results in clearly higher fluorescence 
intensity for the staining exclusively with mAb 13-344. As with lymphoma cells, 
none of the other CD71 antibodies bind to murine surface receptors.  
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Figure 13: Murine immune cells were isolated from the spleen, activated and tested for 
TfR expression, stained with CD71 mAb conjungation and analyzed via flow cytometry. 
Non- stimulated cells have been stained immediately after isolation with the mAbs presented 
before. Activation of immune cells occurred with PMA / Ionomycin and at 37°C.  After 48 hours 
of stimulation, cells were stained and analyzed via flow cytometry. One representative 
experiment of two independent experiments is shown. 
 
Given that fast proliferating cells require more iron for the DNA synthesis plus 
the observed stronger conjugation of these antibodies on leukemia cell lines in 
a similar intensity to the already described antibody mAb VIP-1 support the 
assumption that all presented antibodies recognize epitopes on the TfR. 
However, mAbs VIP-1, 15-221 and 5-528 are specialized to recognize proteins 
only on human tissues, whereas mAb 13-344 also recognize presumable TfR 
proteins on murine cells.  
4.2.3. None of the tested antibodies react to insect cell surface  
 Proteins 
Not only for drosophila but also for other insect organisms, diverse functions 
have been described as being associated with the iron transport protein Tf. The 
N-terminal part of mammalian compared to insect Tf proteins possess highly 
conserved sequence areas, but completely lack the C-terminal part [81]. 
Interestingly, for insects no TfR molecules are known. However, proteins for the 
absorption of the Tf- iron complex must exist. Therefore we tested the binding 
affinity of our 4 mAbs on spodoptera litura (SL) cells. Spodoptera litura belongs 
to the family of Noctuidae insects that cause enormous damages in agriculture 
[12]. Flow cytometry analysis of CD71 mAb VIP-1 labeled SL cells result in no 
detectable aberrance of fluorescence signal compared to the isotype control. 
Similarly, the other mAbs did not bind to any epitopes on the insect cell surfaces 
(Figure 14).  
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Figure 14: Cells of the insect species spodoptera litura have been taken as a 
representative to test the binding capacity of mAbs VIP-1, 15-221, 5-528 and 13-344 in a 
non- mammalian cell approach. The staining occurred according to the standard protocol. 
 
4.3. Human leukemia cell line proliferation is not influenced by 
CD71 mAb treatment  
 
The staining ability of our TfR antibodies confirms the effective conjugation 
especially on surfaces of diverse human lymphoma variants. The important 
function of iron in the cell growth turned the TfR into an important target in the 
cancer therapy. Numerous mAbs directed against the iron absorption 
mechanism have already been described [69, 70, 72]. In order to test the 
presented antibody in this regard, we incubated treated B and T cell lymphoma 
with 3 different concentrations of CD71 antibodies. In regard to the proliferation, 
neither the erythroleukemia cell line K562 nor the Jurkat T cell or the Hodgkin`s 
lymphoma KM-H2 cells was inhibited by antibody treatment (Figure 15). 
Concerning the incorporation of methyl-3-thymidine into the DNA during the cell 
population growth, the scintillation detector recorded similar counts for antibody 
incubation and non-treated cells. The spreading of the Burkitt lymphoma Raji 
offered in the same way no effects related to the antibody treatment (data not 
shown).  
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Figure 15: Human lymphoma cell lines were cultivated in 1640 RPMI medium including 
10% FCS. For the growth analysis in the presence of CD71 antibodies 3*10
4
 Jurkat (A) (n=1), 
KM-H2 (B) (n=1) and K562 cells (C) (n=3) were cultivated in 24- well plates. Jurkat cells grew 
for 72 hours, KM-H2 cells and K562 cells for 24 hours. The influence of antibodies on the 
lymphoma accretion was tested in 3 concentrations: 10 µg/ml, 1 µg/ml and 0,1 µg/ml. For each 
condition, antibodies were pipetted into triplets and the cell growth monitored via the 
incorporation of methyl-3H-thymidine. Mean ± SD of triplicate measurements is represented.    
4.4. Molecular characterization of epitope specifity 
 
4.4.1. mAbs VIP-1 and 5-528 bind to overlapping epitopes  
In order to characterize the epitopes of our CD71 mAbs, cross inhibition assays 
were performed. Based on the fact that previously presented antibodies bind to 
external parts of TfRs, we used the fast dividing Reed- Sternberg cell type KM-
H2 for the accomplishment of epitope mapping analysis. For the prevention of 
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unspecific antibody fixation via Fc receptors, cells were preincubated with 
Beriglobin. The addition of CD71 mAbs to cells lead to the occupation of 
antibody specific binding sites. Disguised epitopes are therefore not detectable 
for conjugated antibodies possessing identical or overlapping binding sites. For 
the visualization of conjugated antibodies we used flow cytometry analysis 
technology.    
Beside the epitope occupation by its respective conjugated antibodies, mAb 13-
344, as well as mAb 15-221, shows no effect on the binding intensity for any of 
the other mentioned antibodies (Figure 16 A and 16 B). Our cross inhibition 
studies showed a strong reduction in the linkage of conjugated VIP-1 antibodies 
to cells pretreated with mAb 5-528 (Figure 16 C). In similar way KM-H2 cells 
pre-incubation with VIP-1 immunoglobulin resulted in a clearly inhibited binding 
capacity of conjugated 5-528 mAbs (Figure 16 D).  
 
Figure 16: Combination of mouse anti- human TfR (CD71) mAbs to identify overlapping 
epitope regions.  For the accomplishment of the cross inhibition assays, KM-H2 cells were 
pretreated with various CD71 mAbs for 30 minutes at 4°C (antibody names noted inside of the 
boxes) and thereupon stained using the fluorochrome conjugated (FITC or PE) variants of each 
CD71 antibody (A: 13-344; B: 15-221; C: VIP-1; D: 5-528). Detection of conjugated antibodies 
bound to TfR epitopes occurred via flow cytometry analysis. Black lines: conjugated CD71 
mAbs, gray dotted lines: negative control. One representative experiment of 10 independent 
experiments is shown. 
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However, the strong intensity of VIP-1 binding site inhibition through mAb 5-528 
pretreatment is not exactly reflected by mAb VIP-1 pre-incubated cells stained 
via conjugated 5-528 antibodies. These results lead to the assumption that 
mAbs VIP-1 and 5-528 bind to overlapping epitopes, but mAb 5-528 covers TfR 
sequences shared by both antibody variants with higher efficiency. The non- 
overlapping characteristics of the half of our tested antibodies (15-221 and 13-
344) reflect the enormous range of 671 amino acids of the extracellular receptor 
domain [7]. 
4.4.2. Immunoprecipitation of CD71 protein from the Raji cell line 
recognized by CD71 mAbs 
Since we observed overlapping epitope regions recognized via mAbs VIP-1 and 
5-528 on the cell surface of KM-H2 cells, we were interested in a more detailed 
characterization of the sequence areas bound by mAbs VIP-1, 15-221, 5-528 
and 13-344. For epitope precipitation from the human Raji B cell lymphoma line 
we used sheep anti mouse dyna beads coated with human CD71 mAbs. The 
immune staining of extracted cell proteins reflected the data obtained with cross 
inhibition assays. A strong reduction of fluorescence intensity was detectable for 
conjugated variants of identical antibodies that were used prior to this staining 
for the protein isolation process. TfR fragments assigned with mAb VIP-1 
resulted in an obvious weaker fluorescence signal for mAb 5-528 isolated 
proteins as well as for the precipitation using mAb VIP-1 (Figure 17 A). 
Similarly, when mAb 5-528 was used for the protein staining, we observed a 
reduced fluorescence signal also for protein precipitation via mAb 5-528 but 
also for mAb VIP-1 (Figure 17 C). Immunostainings with mAbs 15-221 or 13-
344 showed no decrease in the fluorescence intensity for protein isolates 
accomplished with any of the other three antibodies. 
The similarity between the results of the previously described epitope mapping 
and immunostaining of precipitated proteins of the latter confirmed that mAb 5-
528 and VIP-1 share overlapping epitope sequences. Nonetheless the stronger 
inhibition for the binding of antibody mAb VIP-1 while the epitope occupation 
with mAb 5-528 observed in epitope mapping analysis and therefore the higher 
sequence recognition affinity for mAb 5-528 as for mAb VIP-1 were not 
confirmed in the immunostaining of precipitated antigens. Protein extraction by 
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using mAb 5-528 resulted in similarly fluorescence intensity values for the 
staining with conjugated antibody mAbs VIP-1 and 5-528. Similar fluorescence 
data were obtained for the TfR isolation with antibody mAb VIP-1. 
 
Figure 17: Extraction of Raji protein sequences detected by TfR mAbs. Lyses of cultivated 
Raji cells resulted via mixture with RIPA buffer for 1 hour at 4°C. The lysate was centrifuged, 
cell debris discarded and the supernatant kept ready for the incubation with prepared dyna 
beads. Sheep anti- mouse dyna beads were coated with 10 µg/ml CD71 mAbs, washed and 
rotated with extracted Raji cell proteins overnight at 4°C. Beads were coated with: A: VIP-1, B: 
15-221, C: 5-528 and D: 13-344. Protein parts bound to the coating antibodies were stained 
using conjugated CD71 mAbs (antibody names inside the rectangles). The fluorescence 
intensity is compared to the negative control staining (gray, dotted graphs). One representative 
experiment of two independent experiments is shown. 
 
In order to characterize CD71 mAbs linked proteins, we determined the 
molecular weight of the antigens coupled to the beads/ antibody complex. The 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS—PAGE) 
technique enables the separation of proteins in regard to their size and charge 
and therefore the identification of varying peptides. To gain specific information 
about the proteins recognized by all four mAbs, we separated antibodies from 
the beads via high speed centrifugation and analyzed bound proteins via SDS 
gel electrophoresis. Figure 18 shows the peptide distribution visualized through 
the silver staining method. Protein extracts of CD71 mAb VIP-1 coated beads 
(second lane from the right border) plus peptides isolated through the other 
b
e
a
d
 n
u
m
b
e
r
b
e
a
d
 n
u
m
b
e
r
b
e
a
d
 n
u
m
b
e
r
VIP-1
15-221
5-528
13-344
VIP-1 VIP-1VIP-1
15-221 15-221 15-221
5-528 5-528 5-528
13-344 13-344 13-344
A B C D
b
e
a
d
 n
u
m
b
e
r
fluorescence intensity (log 10) fluorescence intensity (log 10) fluorescence intensity (log 10) fluorescence intensity (log 10)
RESULTS 
 
64 
 
three tested mAbs possess a molecular weight of 95 kDa (Figure 19, rectangle 
framed). A second peptide fraction was identifiable at the 75 kDa band (Figure 
19, circular framed) on the gel. The 95 kDa comes up with the molecular weight 
of the membrane anchored variant of TfR monomers, whereas the 75 kDa 
bands refer to the soluble form of TfR proteins. The soluble TfR variant is 
described as a truncated variant of CD71 proteins and has been detected at 
both 75 kDa [67] and 85 kDa [3]. The band pattern at the same size for all of the 
tested CD71 mAbs confirms the recognition of the same peptide. The 
precipitation process was further achieved with an antibody that does not bind 
to human proteins and served as isotypecontrol. 
For the characterization of the total assemblage of the TfR protein expression of 
diverse human and murine B or T cell lymphoma, cells were lysed before TfR 
proteins were separated and blotted onto a nitrocellulose membrane by using 
the SDS-PAGE technique. To monitor whether the proteins transfer worked 
efficiently, we used mAb 8-301 that is directed against the cytoplasmic region of 
the prototypic transmembrane tyrosine phosphatase CD45 [89]. As a second 
control antibody we detected MHC I proteins. However, membrane incubation 
with murine antibody VIP-1, 15-221, 5-528 or 13-344 did not lead to the 
detection of any CD71 proteins within any of the cell lysates.  
 
Figure 18: Antigen conjugated to antibody coated dyna beads were separated, loaded on 
a 10% SDS gel and visualized via silver staining reagents. Protein extractions were 
electrophoresed under reduced conditions. Precipitates of the already characterized mAb VIP-1 
act as positive control whereas proteins isolates with VIAP, a calf intestine alkaline 
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phophatsase- specific antibody, served as negative control. The strong distinguished bands at 
50 kDa show the heavy chain fragments of respective antibodies.  
 
4.5. CD71 is upregulated on activated dendritic cells 
 
As shown before, mAbs VIP-1, 15-221, 13-344 and 5-528 bind strongly to 
activated and fast proliferating human lymphoma cell lines. Stimulated cells 
derived from myeloid progenitors are important mediators of the innate and 
adaptive immunity and some of them are known to accumulate iron. Brinkmann 
et al. reported 2007 [5] that non- activated CD14+ dendritic cells (DCs) freshly 
isolated from human blood samples show higher TfR expression than 
comparable tissue cells. However, stainings via our tested CD71 mAbs resulted 
in only limited TfR detection on the cell surface of non-activated monocyte 
derived DCs (Figure 19 A). To analyse the TfR upregulation during the 
activation of human DCs, the bacterial components peptidoglycan (PGN) or 
lipopolysaccharide (LPS) or the human rhinovirus 14 (HRV14) were provided as 
respective stimuli. Labeling of conjugated antibodies targeted to the TfR 
happened 48 hours after stimulation. On the strength of antigen detection (e.g.: 
LPS, PGN…) as well as the linkage of cytokines (TNFα, IL-1…) to its respective 
receptors lead to a structural reorganization of DCs. This reorganization 
concerns mainly the conversion of antigen detecting cells into professional 
APCs and in correlation with this to an increased surface expression of 
lymphocyte co- stimulatory ligands, adhesion molecules and antigen presenting 
complexes [83]. Human leukocyte antigen- DR (HLA-DR) is the human homolog 
to the murine MHC class II peptide complex and is strongly expressed on 
surfaces of professional APCs. The strong appearance correlates with an 
increased production and minimized inclusion of these proteins as well as the 
nearly 100 fold expanded half life time [83]. None- stimulated DCs exhibit a 
relative high level of HLA-DR mRNA in the cytoplasm, but only a limited number 
of surface proteins [83].  
This statement is also confirmed by the reduced HLA-DR receptor detection on 
the surface of DCs in contrast to LPS or PGN stimulated and structural modified 
APCs (Figure 19, A-C). Similar data were obtained for the surface staining of 
the TfR, whereupon the fluorescence signal for CD71 proteins was much lower 
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than for the expression of HLA-DR peptides. Activation of DCs via LPS and 
PGN (Figure 19 B + C) resulted in strong expression of TfRs detected by all 
tested CD71 mAbs as well as from the antigen presenting peptide HLA-DR. 
Contrarily, when DCs were mixed with HRV particles, mAb VIP-1, 15-221 and 
5-528 showed only a very weak reactivity with antigens on DC surfaces. 
Equally, the activation marker HLA-DR shows no upregulation on the cell 
surface. Compared with other tested CD71 mAbs which are added under the 
same stimulatory conditions, the fluorescence intensity of mAb 13-344 
increases only minimal. 
Figure 19: Comparison between non-stimulated (A) and activated (B-D) DCs concerning 
the expression of surface TfRs. DCs were maintained by cultivation of monocytes with IL-4 
and G-CSF in 1640 RPMI medium supplemented with 10%FCS for 5 days. Activation followed 
by addition of LPS, PGN or HRV for two days, before DCs were stained and analyzed via flow 
cytometry. One representative experiment of two independent experiments is shown.  
4.5.1. The activation process of dendritic cells is not influenced by any of 
the tested mAbs  
Because of the evidence of the high appearance of CD71 mAbs on the cell 
surface of stimulated DCs, we were interested to verify whether the activation 
state is affected by any of the CD71 antibodies. For that purpose DCs were 
repeatedly stimulated with LPS, PGN or HRV14 and simultaneously treated with 
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respectively one immunglobuline variant of our tested mAbs (Figure 21). The 
stimulation via PGN or LPS resulted in a strong expression of activation 
molecules CD1a, CD40 and HLA-DR on the cell surface (Figure 20). CD40 is 
known to be highly expressed on APCs and its attachement to ligands on B or T 
cells is associated with the expression of costimulatory molecules on both APCs 
and lymphocytes [84]. Costimulatory molecules again are important to prevent 
the anergic behavior of lymphocytes. CD1a and HLA-DR surface molecules are 
both highly expressed on APCs with similar functions in the presentation of 
antigens. CD1a belongs to the CD1 group of MHC like structures and present 
mainly lipid components of the cell membranes of diverse microorganisms [85].  
 
Figure 20: Quality control of DC stimulation by analyzing three surface proteins that are 
highly expressed in the activated state. Non stimulated cells (A) are opposed to LPS (B), 
PGN (C) and HRV (D) stimulation for 48 hours. Detection of surface receptors occurred with 
conjugated CD1a, CD40 and HLA-DR antibodies (antibody names in respective boxes). One 
representative experiment of two independent experiments is shown. 
 
The binding capacity of labeled antibodies on the surface of non- stimulated 
DCs for all three activation marker is marginal compared to the strongly 
increased fluorescence intensity for LPS or PGN stimulated APCs (Figure 20). 
Figure 21 demonstrates that none of the TfR antibodies compromise the 
intensity of the activation process from LPS stimulated DCs. Similar data was 
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obtained for the stimulation via PGN. However, activation of DCs via human 
rhinovirus (R-DC) resulted in clearly reduced expression of all three activation 
markers compared to the other stimuli (Figure 20 D). Given that DCs are not 
activated in the presence of HRV and based on the fact that stimulated as well 
as non- stimulated DCs are not influenced by the treatment with any of the 
tested CD71 mAbs, we were not surprised to note as well no effects of antibody 
treatment simultaneously to HRV stimulation. 
 
Figure 21: Activation profile of DCs treated with LPS for 48 hours alone (A) or in 
combination with CD71 mAbs (C-F). Activation of DCs happened also including PGN or HRV 
(data not shown) for stimulation. None of the tested Tfr binding antibodies reduce the 
upregulation of activation surface molecules. One representative experiment of four 
independent experiments is shown. 
4.5.2. Treatment of stimulated DCs with CD71 mAbs has down 
modulating effects on the surface TfR expression 
After observing that stimulation and simultaneously incubation of mAbs did not 
lead to alterations on the DC activation behavior, it was of interest if TfR surface 
expression is influenced during activation plus simultaneously CD71 antibody 
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treatment. Therefore dendritic cells were mAb treated and stimulated with LPS, 
PGN and HRV as described before and afterwards marked with conjugated 
CD71 mAbs.  
 
Figure 22: Characterization of the TfR surface expression on 48 hours PGN stimulated 
DCs combined to respectively one of the mAbs (clone names specified on the right side).  
All of the tested CD71 mAbs cause down regulatory effects on the surface expression of TfR 
proteins. The strongest inhibitory effect is detectable for treatment with mAb 15-221 (D), 
whereas mAb 13-344 (E) addition to cultivating DCs has moderate consequences. One 
representative experiment of three independent experiments is shown. 
 
Pre-incubation of CD71 mAbs result in a clear reduction in the surface TfR 
emergence. The strongest down regulatory effect was detectable for DC 
treatment with mAb 15-221 (Figure 22 D) followed by mAbs 5-528 (Figure 22 C) 
and VIP-1. (Figure 22 B) mAb 13-344 (Figure 22 E) on the other hand shows 
only a limited effect on the surface arrival of TfR proteins. The lower count of 
surface receptors for the respective antibody therapies was obtained in an 
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identical order for LPS stimulation. However, DC incubation of HRV combined 
to CD71 mAbs showed almost no effects given that HRV stimulation alone lead 
to only a weak detection of CD71 surface molecules. The reduced expression of 
TfR proteins on surfaces of stimulated cells lead to the assumption that 
incubation of antibodies directed against the TfR results in the accumulation of 
the receptor proteins in the cell interior, maybe through the inhibition of the 
recycling mechanism back to the cell surface. The theory of receptor protein 
accumulation in the cell interior is confirmed by the in vitro study of the TfR 
internalization process through the conjugation of mAb 13-344 on the DC 
surface [82].TfR antibodies do not alter the cytokine secretion of dendritic cells 
After 48 hours of respective CD71 antibody plus LPS, PGN or HRV14 stimuli 
incubation, the cytokine dispersion of the DC supernatant was determined via 
LUMINEX. Based on the activation of DCs, the total cytokine production is 
increased for stimulation with the bacterial components LPS and PGN. But still 
only slight effects induced by TfR mAbs were noted for any of the secreted 
cytokines. Minimally reduced cytokine data were observed for IL-8, IL-12p40 
and IL-12p70 for the treatment with mAb 15-221. On the other hand a slightly 
increased IL-1β expression was observable when DCs were incubated in 
combination with mAb 13-344 (Figure 23). These cytokine variances are only in 
a small range and it seems to be unlikely that these aberrations affect the 
behavior of any cells. Nearly no cytokine secretion was detectable for HRV 
stimulated DCs (unpublished results).  
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Figure 23: The combination of stimuli plus CD71 mAbs were incubated to DCs for 48 
hours and analyzed via LUMINEX. Respective stimuli are denoted under the CD71 mAbs. 
Results of one representative experiment of three independent experiments are shown.  
 
4.6. T cell proliferation mediated by activated plus CD71 mAb 
pretreated DCs is not affected  
 
For the activation process of DCs as well as for T cells it is probable that iron 
has important functions. Furthermore it is evident that this trace element is 
required for the function of the DNA synthesis via ribonucleotide reductase 
during the proliferation of each cell. Inhibition of TfRs leads consequently to a 
non-functional T cell increasement. However, the previously collected data 
showed no effects of CD71 mAb treatment on the activation process of DCs. To 
test the implication of antibody incubation on the activation process of T cells 
mediated by alloreactive APCs, DCs were again mixed with respective 
antibodies and simultaneously activated via LPS, PGN or HRV14. For the 
initiation of the mixed leukocyte reaction (MLR), T cells were added 48 hours 
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after DC treatment and incubated for 5 days. Stimulation of DCs implicated in 
the rise of methyl-3H-thymidine integration into newly formed T cells from 10 
000cpm up to 50 000cpm, whereupon the highest values are attained for PGN 
stimulation (Figure 24). Equally to the previous mentioned data of the DC 
activation by using different stimuli and compared to the other stimuli we 
detected also a strongly limited T cell proliferation by DC stimulation with 
HRV14. Concerning the effects of antibody treatment, we observed only 
minimal fluctuations in the thymidine incorporation between the different mAbs. 
The degree of the alloreactive reaction among non-treated DCs and those 
incubated with one of the four mAbs is equally low. This data confirms prior 
microscope observations where neither proliferation enhancement nor inhibition 
between the various antibodies has been noted. In summary none of the tested 
CD71 antibodies combined to different stimuli during the pre-incubation process 
with DCs shows any implications on the T cell proliferation during the MLR.  
 
Figure 24: Monitoring of the T cell proliferation mediated by two days CD71 antibody pre-
treated DCs. Various antibodies and stimuli were combined and mixed to DCs cultivated in 
1640 RPMI medium including 10% FCS. 48 hours later the mixed leukocyte reaction was 
initiated by 5*10
5
 preprocessed DCs mixed with 10
5
 T cells. For the determination of the T cell 
proliferation, methyl-3H- thymidine was added 5 days later. Integration of methyl-3H-thymidine 
into the newly formed DNA was detected via scintillation counter. Results of one representative 
experiment of two independent experiments are shown. Mean ± SD of triplicate measurements 
is represented. 
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4.6.1. MAb 15-221 or VIP-1 directly added at the beginning of the mixed 
leukocyte reaction efficiently inhibit T cell proliferation 
In a second mixed leukocyte approach, DCs were activated in the same way as 
described above but unlike to the first assay, antibodies directed against TfR 
proteins were added simultaneously with the T cells at the beginning of the 
MLR. Similarly to the first approach we observed the strongest T cell 
proliferation induction via DC stimulation with PGN followed by LPS activation. 
Addition of TfR antibodies at the same time point as T cells resulted in a clear 
inhibition of T lymphocyte proliferation in MLRs incubated with antibodies VIP-1 
or 15-221. Contrarily a slightly enhanced T cell expansion is observable for the 
treatment with mAb 13-344. Both inhibition and enhanced T cell proliferation are 
independent of the stimuli variant. These data are opposite to the result of the 
first MLR and raise the question of which part of the IS is influenced by the 
addition of CD71 mAbs directly at the beginning of the MLR. Given that we 
found no influence of antibody treatment on the DC activation process, we 
assumed rather a correlation with a nonfunctional T cell activation and out of it 
resulting proliferation process.  
 
Figure 25: Previously activated DCs were combined to T cells of a different donor to set 
up a mixed leukocyte reaction (MLR). Stimulated DCs were rendered in a 96 well-plate and 
TfR antibodies were subjoined simultaneously with T cells in 96 well plates. Methyl-3H-
thymidine was added after five days of incubation and the degree of cell incorporation analyzed. 
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Results of one representative experiment of two independent experiments are shown. Mean ± 
SD of triplicate measurements is represented. 
4.7. In vitro stimulation of T cells in the presence of CD71 mAbs 
influences cytokine production and proliferation  
 
The observation of the strongly reduced T cell multiplication while mAb VIP-1 
and 15-221 treatment at the outset of the MLR is contrary to the other so far 
obtained results. Indeed all of our tested antibodies showed the capability to 
bind to human cell surfaces but none of them possess inhibitory functions 
concerning the proliferation of human B and T cell lymphoma. Moreover the 
incubation of DCs with TfR antibodies in combination with diverse stimuli 
manifested in the same way no influences in the maturing process into 
professional APCs. These facts indicate that mAb VIP-1 as well as 15-221 block 
a supposed iron dependent intermediate step during the T cell activation 
process. To test this assumption we stimulated T cells via plate bound CD3 
(OKT3) antibodies alone or in combination with CD28 or CD63 co-stimulatory 
antibodies. Additional soluble CD71 mAbs were added before the cytokine level 
in the supernatant and the intensity of T cell increasement were determined 48 
hours after initiation of the stimulation process. A clear reduction of the cytokine 
secretion was detectable for IL-10, IL-13, IL-17 plus IL-22, when T cells were 
treated with mAb VIP-1 or 15-221. In most of the data we observed a stronger 
reduction in the cytokine production of mAb 15-221 incubated T cells than for 
the treatment with mAb VIP-1 (Figure 23). Equally considerably lower cytokine 
levels were perceived for the IL-2 secretion after the incubation with mAb 15-
221.  
IFNγ is produced by various cells of the innate immunity (mainly APCs and 
macrophages) and its detection by type II receptors lead to an increased 
differentiation of TH4
+ cells into the TH1 subgroup and controls the activation of 
cells mainly of the innate immunity (e.g. NK cells) [58]. However, the main 
producer cells of IFNγ are TH1 cells, a subcategory of the T helper lymphocytes 
[23, 58]. Indeed the analysis of the T cell supernatant resulted in strongly 
increased levels of IFNγ levels but contrary to nearly all the other cytokines we 
detected barely any reduction for the T cell treatment with any of the tested 
CD71 mAbs. A second apparently not affected cytokine expression concerns 
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the volume of the IL-4 production. Beside mast cells, the highest part of IL-4 is 
established via the T helper lymphocyte derived TH2 cells [53]. As expected, in 
vitro stimulation of T cells showed a high secretion of IL-4, but none of the 
antibodies demonstrated a clearly noticeable effect on the cytokine production 
process. The variance of activation stimuli between CD3 plus CD28 or CD3 plus 
CD63 also did not change the properties of CD71 mAb treatment on the T cell 
cytokine secretion pattern.  
 
 
Figure 26: T cell stimulatory CD3 (OKT3) immunoglobulins alone or in combination with 
CD28 co-stimulatory antibodies were fixed on the bottom of 96- well plates and incubated 
with 10
5
 T cells plus soluble CD71 mAbs  for 48 hours. T lymphocytes treated with mAb VIP-
1 or 15-221 exhibit a clear reduction in the secretion of IL-10, IL-13, IL-17 and IL-22, whereas 
the level of IL-2 cytokines is mainly reduced by treatment with mAb 15-221. Contrary none of 
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the tested antibodies influence the IL-4 and IFNγ cytokine secretion. Similar results were 
obtained for the combination of OKT3 plus CD63 antibodies. Results of one representative 
experiment of two independent experiments are shown.  
The evaluation of the T cell proliferation accords with the results obtained from 
the cytokine analysis. For all three stimuli combinations T cell propagation is 
potently reduced for the respective addition of one of the two mAbs VIP-1 or 15-
221. The highest T cell augmentation was detectable for the antibody 
combination OKT3 plus CD28. In all assays we detected a higher decrease for 
the treatment with antibody 15-221 than for mAb VIP-1.  
  
Figure 27: In vitro T cell proliferation assay mediated by plate bound CD3 antibodies 
alone or joined with either CD28 or CD63 antibodies. T cell proliferation was stimulated by 
plate bound antibodies directed against CD3 chains of the TCR alone or in combination with 
antibodies targeted on co-stimulatory ligands. The T cell augmentation was analyzed after 48 
hours incubation and detected via incorporation of methyl-3H-thymidin into newly formed DNA 
18 hours after addition to the proliferation assays. Results of one representative experiment of 
two independent experiments are shown. Mean ± SD of triplicate measurements is represented.  
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5. DISCUSSION 
 
Iron is essential functions for the activity of diverse enzymes, whereas abnormal 
regulation implicates harmful effects through low or high cellular concentrations. 
The integration process of iron into the cell interior depends on the endosomal 
absorption of iron loaded Tf proteins bound to TfRs on cell surface. This study 
was constructed on four murine mAbs that recognize epitopes of the human TfR 
(CD71). In the first part of the study we confirmed that all mAbs are specific for 
CD71. Binding studies on fast dividing B and T cell lymphoma showed the 
binding of mAbs VIP-1, 15-221 and 5-528 on the surface of Daudi, Raji, K562 
and also on Jurkat cell. Antibody 13-344 bound to murine AKR and BW cell 
lines as well as to above mentioned human cell lines. MAb VIP-1 was already 
known to recognize specifically human CD71 proteins [78- 80] and was 
therefore used as a positive control. The murine BW cell line expressing the 
human surface TfR is similarly recognized by all four tested antibodies and 
exhibit similar fluorescence intensity for staining. This was further confirmed by 
silver stain analysis, where isolates precipitated with CD71 mAb coated beads 
showed a band at molecular weight similar to that of CD71 monomers. The 
upregulation of TfRs on the surface of pre-stimulated DCs have been already 
reported [24, 27] and was also further confirmed in this study. Previously 
characterizations of mAb 13-344 in our lab showed further a strong conjugation 
to pre-stimulated DCs [82]. Addition of CD71 mAbs –VIP-1 or 15-221- directly to 
a MLR resulted in a strong inhibited T cell proliferation. These results were 
surprising, because co-cultivation of monocytes with mAb VIP-1, 15-221, 13-
344 or 5-528 showed influences neither on the differentiation of DCs nor on the 
production of cytokines. Hence we were interested if inhibitory effects are via 
DCs by delaying activation signals or probably by down-regulating of 
costimulatory surface molecules. Another possibility could be also its effect via 
T cell activation.  Similarly, in an in vitro stimulation assay we were able to 
demonstrate an inhibitory effect of both antibodies VIP-1 and 15-221 on the T 
cell proliferation.  
Probably the most prominent CD71 mAb described in the literature, 42/6 
represses efficiently Tf attachment to its receptor on many human cell types 
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[70-73]. Similarly to other CD71 mAbs, the mechanism for the inhibition of this 
IgA isotype is not completely clear. One theory acts on the assumption that 
mAb 42/6 causes sterical changes in the extracellular part of the receptor [73], 
whereas other opinions are based on a competitive occupation of nearby areas 
of Tf binding sites and thus inhibiting the attachment of iron loaded Tf on the 
receptor [70]. Multivalent mAbs mainly directed against murine CD71 
determinants are supposed to cross-link TfRs on cell surfaces. It has been also 
shown that monomeric antibodies of the IgG isotype enhance the degradation 
of surface TfRs on murine tumor cells [49, 72]. Concerning the formation of the 
IS, numerous mAbs directed against the TfR on the surface of T cells are 
described [31]. Antibody FG 2/12 binds proximate to the TF binding site and 
seems to reduce the binding areas for DC through sterical retardation of Lck 
and CD3ε conglomeration. Addition of mAb FG 2/12 seems therefore to inhibit 
signal transduction prior IS formation [31]. Another CD71 mAb, FG 1/5, has 
minimal effects on NK cell mediated cell lysis. The context between NK cell 
mediated cell killing has been detected with mAb 2/12 [87]. The CD71 mAbs 
tested in our study are IgG immunoglobulins similarly to those mentioned 
before. Cultivation of human or murine lymphomas in combination with 
respective CD71 mAbs did not alter the cell multiplication. The unaffected cell 
expansion after treatment with mAbs VIP-1, 15-221, 5-528 or 13-344 indicates 
that respective antibodies do not cover the stalk region or the lateral receptor 
domains of Tf attachment sites and therefore do not compete with Tf for binding 
areas. None of the four CD71 mAbs prevent the internalization process of iron 
loaded Tf in monocyte derived DCs and probably do therefore not compete for 
the iron dependent differentiation process. However, for some cell lines 
alternative iron uptake mechanisms can be observed. For the exclusion of the 
iron absorption by unknown alternative ways, we performed proliferation assays 
in FCS free medium in parallel to the cell augmentation in standard medium. 
Beside nutrients, FCS contains dissolved iron components and probably also 
calf Tf proteins similar to that of human. Cells incubated in the medium lacking 
FCS did not grow and most of them died within two days. Nevertheless it is hard 
to conclude that cells died exclusively based on the Tf deletion or iron 
restriction, because FCS contains other nutrients as well as cell growth factors. 
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A more detailed view on the antibody binding sites showed that mAb VIP-1 and 
5-528 recognize identical epitopes. The even more attenuated fluorescence 
signal of VIP-1 antibodies for mAb 5-528 pretreated KM-H2 cells, changes to a 
less attenuated signal when KM-H2 cells are preincubated with mAb VIP-1 and 
stained with mAb 5-528. This demonstrates that mAb 5-528 covers a larger part 
of mAb common shared sequence area than antibody VIP-1. The mutual 
inhibition is maybe of interest for the preparation of an antibody binding map 
from the whole extracellular domain of human TfR proteins, but definitely for the 
analysis of TfR surface expression via conjugated immunglobulins. 
In 2002, sequencing of the murine genome identified a tremendous sequence 
similarity with the human genome. TfR proteins isolated from mice and 
separated via SDS- PAGE indicated a molecular weight of 200 kDa (100 kDa 
for each monomer), that differ only in 10 kDa from human non-reduced receptor 
proteins [47]. The structural homology between human and mice TfR proteins 
may permit the detection of evolutionary conserved sequence regions in both 
species and probably account for the crossreaction of mAb 13-344 on human 
and murine CD71 proteins. Exactly as mammals, insects express ferritin and Tf 
proteins. The structure of Tf proteins for a few insect species exhibit also 
similarities with that of comparable peptides in mammalians [46], but in insects 
there is no evidence either for the existence of iron regulatory proteins, such as 
Hepcidin or ferroportin-1, or for the iron absorption mechanism via Tf cell 
surface receptors [48]. However the iron uptake system in arthropods is 
regulated, it is not surprising that none of our tested anti- CD71 mAb detected 
any proteins on the surface of cells from the moth type Spodoptera litura.  
In the course of maturation from monocytes to DCs, more and more TfR 
proteins appear on the cell surface [24].The strong binding of conjugated CD71 
antibodies after 48 hours of continuous DCs activation is in accordance with the 
already described strong expression of TfR on stimulated DCs. It is surprising 
that non proliferating cell types possess cell surface receptors in a similar 
fashion compared to rapidly growing lymphoma cells. The further development 
of lymphoid and myeloid progenitors differs in many details, starting from 
participating cytokines to the organ where maturation occurs. Especially for 
lymphocytes it is reported that iron plays important roles in the maturation 
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process and in the transduction of environmental signals [22, 31, 62]. Iron 
seems to be equally associated with the development and activation process of 
DCs and would demonstrate a common feature between both lineages.  
DC stimulation via PGN or LPS and synchronous treatment with mAbs VIP-1, 
15-221, 5-528 or 13-344 revealed no deviation in the strong expression of 
molecules associated with the activation process. Based on probably the 
important effect of TfRs during DC development plus from the results of 
unaffected lymphoma proliferation assays lead to suggestion that none of the 
tested antibodies bind on sequence areas essential for the TfR/Tf/iron complex 
internalization activity. Apart from the iron integration, TfRs are suspected to 
influence the signal transduction in lymphocytes via tyrosine phosphorylation of 
B- or T cell receptor associated ITAM motifs. Since DCs are non- proliferating 
cells, it could be speculated, that similar events account for the upregulation of 
TfRs on DC surfaces. Such events may influence the conversion into 
professional APCs or the migration to secondary lymphoid organs (e.g.: 
upregulation of surface proteins). Concerning the morphological changes in 
CD71 mAb incubated cells, no deviations were noted compared to non- treated 
DCs. In spite of this the appearance of TfRs increases in later developmental 
steps from monocytes toward DCs and suggests the requirement of iron for the 
formation process. The almost unchanged cytokine profile of mature DCs 
stimulated with PGN or LPS alone as well as in the combination to antibody 
treatment agree with the unaffected pattern of activation marker and confirms 
that none of the tested antibodies affect the maturation from DCs to APCs.  
Surface stainings of stimulated DCs by associates of our lab in 2004 showed a 
clear reduction of the fluorescence signal after a time period between 30 and 
120 minutes when samples remained at room temperature [82]. Fluorescence 
microscopic analysis verified the internalization and accumulation of applied 
antibodies 13-344 in the cell interior (Figure 28).  
In a similar way we observed a clear reduction of TfR appearance on DC 
surfaces after the incubation with stimuli and CD71 mAbs for two days. It is 
likely that the decreasing fluorescence signal for TfR proteins results from the 
same mechanism. However the receptor mediated integration activity into 
endosomes has been observed independently to the attachment of Tf to its 
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receptor and CD71 recycle back to the cell surface within a short time period [6, 
13, 14]. According to that conclusion we would not expect to observe down 
modulatory effects of TfR surface proteins based on the treatment with mAbs 
that show no effects on DC differentiation. 
 
 
Figure 28: Accumulation of fluorescence labeled CD71 mAb 13-344 in the cell interior after incubation 
at room temperature for 120 minutes. Picture of the receptor mediated uptake adapted from [82].  
On the other hand, activated DCs produce TfRs in large quantities and cross 
linkage of antibody as well as receptor molecules within the cytoplasm may 
prevent the recirculation to the cell surface. It is reported that TfRs possess 
important functions in the establishment and maintenance of IS [31]. The 
reduced expression of surface CD71 molecules on stimulated DCs after mAb 
treatment implicated no effects in regard to the activation process of T cells. 
Hence it is likely that after formation of the IS only a limited number of receptors 
are required for the maintenance of the contact sites. The results of MLRs 
where T cells were added to CD71 mAb pretreated DCs are in strong contrast 
to the second T cell proliferation assay, where antibodies were added 
simultaneously with T cells to pre-activated DCs. The strong repressive effect 
on the proliferation at mAb VIP-1 or 15-221 treated T cells were also clearly 
remarkable via microscopy. Based on the fact that neither VIP-1 nor 15-221 
reduced the activation intensity of DCs and antibody incubation to DCs for two 
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days also showed no influence on the activation of T cells, we assumed a direct 
influence on the later cell type.  
Both the high proliferation of antibody treated Jurkat T- cell leukemia cell line as 
well as the T cell activation by mAb pretreated DCs showed us that the cell 
multiplication process itself seems not to be affected. For that reason we 
assumed that both antibodies interrupt with activities required for the T cell 
activation. It is to notice that leukemia cells, such as Jurkat cells, are immortal 
and strongly uncontrolled concerning the cell cycle modulation and the 
completion of effector functions. Identically to tissue cells of healthy donors the 
synthesis of new DNA is dependent on iron molecules for the usage of 
metalloproteins, but possible consequences on the effector function are not 
observable.  
In vitro stimulation of T cells via CD3 antibodies alone or in combination with 
antibodies directed against costimulatory ligands resulted in a strong T cell 
proliferation also in the presence of CD71 mAb 5-528 and 13-344, but not for 
the treatment with mAb VIP-1 or 15-221. The clear growth repression probably 
caused by strongly reduced activation signal transduction has also been 
observed in the cytokine secretion of IL-2, IL-10, IL-13, IL-17 and IL-22. The 
assumption of reduced activation signal based on CD71 mAbs is in conflict with 
the high secretion of IFNγ that comes along with the activation of T cells and 
fulfills important in vivo challenges in the activation of macrophages and NK 
cells as well as in the upregulation of MHC peptides on cell surfaces [58, 59]. 
IFNγ proteins are decoded by the JAK-STAT translation pathway after detection 
of various cytokines and are secreted into the cytoplasm. The unchanged level 
of IFNγ in the supernatant is surprising when referred to the enormous growth 
reduction in mAbs VIP-1 and 15-221 treated T cells. Beside genes for 
cytokines, the JAK-STAT signaling mechanism include many regulatory 
proteins that also encode for IFNγ proteins [59]. This positive feed-back loop 
may explain increasing levels of IFNγ. IFNγ itself influences the protein 
assembly further through the CD4+ precursor T cells differentiation into the TH1 
subgroup, which belongs again to the main IFNγ producers. However both 
regulatory mechanisms do not explain the unchanged cytokine quantity 
between augmented and inhibited cell growth. Moreover cytokines IL-2, IL-10, 
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IL-13 and IL-22 are equally produced by the participation of JAK-STAT signaling 
pathways, but contrary to IFNγ we detected clearly lower levels upon mAb VIP-
1 or 15-221 incubation.  
In summary, the presented data demonstrates the binding of four monoclonal 
antibodies to epitopes of the human TfR. Antibody 13-344 possesses additional 
binding reactivity to similar surface proteins on murine lymphocytes. None of the 
antibodies influence either the high proliferative capacity of lymphoma cells or 
suppress DC activation. However, immunosuppressive functions were detected 
for mAbs VIP-1 and 15-221 related to the T cell, increase the probability of 
preventing the establishment of signaling pathways important for activation 
processes. Both antibodies are suitable to limit T cell proliferation efficiently 
without affecting DC activation and are therefore a potential starting point in the 
fight against T cell lymphoma. Contrarily mAbs 13-344 and 5-528 show no 
effect on the activation or proliferation of all tested immune cells and can be 
used as a promising diagnostic tool for the detection of cell activation and 
proliferation.                                                             . 
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6. ABBREVIATIONS 
 
abbr. meaning abbr. meaning 
    
APC Antigen-presenting cell MLR Mixed Leukocyte 
Reaction 
Asp Aspartic acid mRNA messenger RNA 
ATP Adenosine Tri-Phosphate MTf MelanoTransferrin 
cSMAC  central SupraMolecular Activation Cluster NADPH Nicotinamide Adenine 
Dinucleotide Phosphate 
pSMAC peripheral SupraMolecular Activation 
Cluster 
NFκB Nuclear Factor κB 
DC Dendritic Cell NK cells Natural Killer cells 
DMT1 Divalent Metal Transporter 1 OH Hydroxyl 
ETC Electron Transport Chain PAMP(s) Pattern associated 
molecular pattern(s) 
Fe II / Fe 
III 
Iron oxidation state II / III PGN PeptidoGlycaN 
HFE gene coding for human hemochromatosis 
protein 
PRR(s) Pattern Recognition 
Receptor(s) 
HLA Human Leukocyte Antigen PTK Protein Tyrosine Kinase 
HRV Human Rhino Virus ROI Reactive Oxygen 
intermediate 
ICAM IntraCellular Adhesion Molecule TCR T Cell Receptor 
Ig Immunoglobulin Tf Transferrin 
IL InterLeukin TfR Transferrin Receptor 
iNOS Inducible Nitric Oxid Synthase TGF Transforming Growth 
Factor 
IRE(s) Iron Response Element(s) Thr Threonine 
IRP(s) Iron Regulatory Protein TNF Tumor Necrosis Factor 
ITAM Immunoreceptor Tyrosine-based 
activation motif 
TRAF TNF Receptor 
Associated Factor 
kDa kilo Dalton UTR UnTranslated Region 
LFA-1 Lymphocyte Function-associated Antigen β2m beta-2 microglobulin 
LPS LipoPolySaccharid   
mAb monoclonal Antibody   
MHC Major Histocomatibility Complex   
 
 
 
 
 85 
 
7. REFERENCES 
 
[1] Papanikolaou, G., Pantopoulos, K., 2005. Iron metabolism  and  toxicity. Toxicol. Appl. 
Pharmacol.: 202 (2): 199-211 
[2] Weiss, G., 2004. Modification of iron regulation by the inflammatory response. Best. 
Pract. Res. Clin. Haematol.: 18 (2): 183-201 
[3] Cook, J.D., Skikne, B.S., Baynes, R.D., 1993. Serum transferrin receptor. Annu. Rev. 
Med.: 44: 63-74 
[4] Testa, U., Kühn, L., Petrini, M., et al., 1991. Differential regulation of iron regulatory 
element-binding protein(s) in cell extracts of activated lymphocytes versus monocytes-
macrophages. J. Biol. Chem.: 266 (21): 13925-13930 
[5] Brinkmann, M., Teuffel, R., Laham, N., et al., 2007. Expression of iron transport proteins 
divalent metal transporter-1, Ferroportin-1, HFE and transferrin receptor-1 in human 
monocyte- derived dendritc cells. Cell Biochem. Funct.: 25 (3): 287-296 
[6] Daniels, T.R., Delgado, T., Rodriguez, J.A., et al., 2006. The transferrin receptor part I: 
Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. 
Immunol.: 121 (2): 144-158 
[7] Qian, Z.M., Li, H., Sun, H., Ho, K., 2002. Targeted drug delivery via the transferrin 
receptor-mediated endocytosis pathway. Pharmacol. Rev.: 54 (4): 561-587 
[8] Rahmanto, Y. S., Dunn, L.L., Richardson, D.R., 2007. The melanoma tumor antigen, 
melanotransferrin (p97): a 25-year hallmark- from iron metabolism to tumorigenesis. 
Oncogene: 26 (42): 6113-6124 
[9] Aisen, P. 2004. Transferrin receptor 1. Int. J. Biochem. Cell Biol.: 36 (11): 2137-2143 
[10] Wang, J., Pantopoulos, K., 2011. Regulation of cellular iron metabolism. Biochem. J.: 434 
(Pt 3): 365-381 
[11] Pantopoulos, K., Hentze, M.W., 1998. Activation of iron regulatory protein-1 by oxidative 
stress in vitro. Proc. Natl. Acad. Sci. USA: 95 (18): 10559-10563 
[12] Itoyama, K., Kawahira, Y., Murata, M., et al., 1999. Fluctuations of some characteristics in 
the common cutworm, Spodoptera litura (Lepidotera: Nuctoidae) reared under different 
diets. Appl. Entomol. Zool.: 34 (3): 315-321 
[13] Trowbridge, I.S., Collawn, J.F., Hopkins, C.R., 1993. Signal- dependent membrane 
protein trafficking in the endocytotic pathway. Annu. Rev. Cell Biol.: 9: 129-161 
REFERENCES 
 
86 
 
[14] Kurten, R.C., 2003. Sorting motifs in receptor trafficking. Adv. Drug Delivery Rev.: 55 
(11): 1405-1419 
[15] Weiss, G., 2002. Iron and immunity: a double-edged sword. Eur. J. Clin. Invest.: 32 (s1): 
70-78 
[16] Walker, B.L., Tiong, J.W.C., Jefferies, W.A., 2001. Iron metabolism in mammalian cells. 
Int. Rev. Cytol.: 211: 241-278 
[17] Lambert, L.A., Mitchell,S.L., 2007. Molecular evolution of the transferrin 
receptor/glutamate carboxypeptidase II family. J. Mol. Evol.: 64 (1): 113-128 
[18] Moura, I.C., Centelles, M.N., Arcos-Fajardo.M., et al., 2001. Identification of the 
transferrin  receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced 
expression on mesangial cells in IgA nephropathy. J. Exp. Med.: 194 (4): 417-425 
[19] Manger, B., Weiss, A., Hardy, K.J., et al., 1986. A transferrin receptor antibody 
represents one signal for the induction of IL 2 production by a human T cell line. J. 
Immunol. 136 (2): 532-538 
[20] Neckers, L.M., Cossman, J., 1983. Transferrin receptor induction in mitogen-stimulated 
human T lymphocytes is required for DNA synthesis and cell division and is regulated by 
interleukin 2. Proc. Natl. Acad. Sci. USA: 80 (11): 3494-3498 
[21] Bayer, A.L., Baliga, P., Woodward, J.E., et al., 1998. Transferrin receptor in T cell 
activation and transplantation. J. Leukocyte Biol.: 64 (1): 19-24 
[22] Salmerón, A., Borroto, A., Fresno, M., et al., 1995. Transferrin receptor induces tyrosine 
phosyphorylation in T cells and is physically associated with the TCR zeta chain. J. 
Immunol.: 154 (4): 1675-1683 
[23] Abbas, A.K., Lichtman, A.H., Pillai, S. (2007). Celllar and molecular immunology. 6th 
edition. Philadelphia. Elsevier 
[24] Pasquier, B., Leppelletier, Y., Baude, C., et al., 2004. Differential expression and function 
of IgA receptors (CD89 and CD71) during maturation of dendritic cells. J. Leukoc. Biol.: 
76 (6): 1134-1141 
[25] Ferlazzo, G., Wesa, A., Wei, W.Z., et al., 1999. Dendritic cells generated either from 
CD34+ progenitor cells or from monocytes differ in their abillity to activate antigen-specific 
CD8+ T cells. J. Immunol.: 163 (7): 3597-3604 
[26] Fagarasan, S., Honjo, T., 2003. Intestinal IgA synthesis: Regulation of front-line body 
defences. Nat. Rev. Immunol.: 3 (1): 63-72 
REFERENCES 
 
87 
 
[27] Testa, U., Petrini, M., Quaranta, M.T., et al., 1989. Iron up- modulates the expression of 
transferrin receptors during monocyte-macrophage maturation. J. Biol. Chem.: 264 (22): 
13181-13187 
[28] Bourgeade, M.F., Silbermann, F., Kühn, L., 1992. Post-transcritpional regulation of 
transferrin receptor mRNA by IFNγ. Nucleic Acids. Res.: 20 (12): 2997-3003 
[29] Byrd, T.F., Horwitz, M.A., 1993. Regulation of transferrin receptor expression and ferritin 
content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin 
and downregulation by interferon gamma. J. Clin. Invest.: 91 (3): 969-976 
[30] Dustin, M.L., Chakraborty A.K., Shaw A.S., 2010. Understanding the structure and 
function of the immunological synapse. Cold Spring Harb Perspect Biol.; 2 (10):a002311. 
[31] Batista, A., Millán, J., Mittelbrunn, M., et al., 2004. Recruitment of transferrin receptor to 
immunological synapse in response to TCR engagement. J. Immunol.: 172 (11): 6709-
6714 
[32] Alarcón B, Mestre D, Martínez-Martín N., 2011. The immunological synapse: a cause or 
consequence of T-cell receptor triggering? Immunology; 133(4):420-5. 
[33] Lee, K.H., Holdorf, A.D., Dustin, M.L., et al., 2002. T cell receptor signaling precedes 
immunological synapse formation. Science: 295 (5559): 1539-1542 
[34] Cua, D.J., Tato, C.M., 2010. Innate IL-17-producing cells: the sentinels of the immune 
system. Nat. Rev. Immunol.: 10 (7): 479-489 
[35] Romagnani, S., 1997. The Th1/Th2 paradigm. Immunol. Today: 18 (6): 263-266 
[36] Ozaki, K., Leonard, W.J., 2002. Cytokine and cytokine receptor pleiotropy and 
redundancy. J. Biol. Chem.: 277 (33): 29355-29358 
[37] Taniguchi, T.1988. Regulation of cytokine gene expression. Annu. Rev. Immunol.: 6: 439-
464 
[38] Ihle, J.N., Kerr, I.M., 1995. Jaks and Stats in signaling by the cytokine receptor 
superfamily.Trends. Genet.: 11 (2): 69-74 
[39] Goetz, F.W., Planas, J.V., MacKenzie, S., 2004. Tumor necrosis factors. Dev. Comp. 
Immunol.: 28 (5): 487-497 
[40] Beutler, B., Cerami, A., 1988. The history, properties, and biological effects of cachectin. 
Biochemistry: 27 (20): 7575-7582 
[41] Kishimoto, T., 1989. The biology of interleukin-6. blood:74 (1): 1-10 
REFERENCES 
 
88 
 
[42] Siegal, F.P., Kadowaki, N., Shodell, M., et al., 1999. The nature of the principal type 1 
interferon-producing cells in human. Science: 284 (5421): 1835-1837 
[43] Zdanov, A., Schalk-Hihi, C., Gustchina, A., et al., 1995. crystal structure of interleukin-10 
reveals the functional dimer with an unexpected topological similarity to interferon γ. 
Structure: 3 (6): 591-601 
[44] Trinchieri, G., 2003. Interleukin-12 and the regulation of innate resistance and adaptive 
immunity. Nat. Rev. Immunol: 3 (2): 133-146 
[45] Hamza, T., Barnett, J.B., Li, B., 2010. Interleukin 12 a key immunoregulatory cytokine in 
infection applications. Int. J. Mol. Sci.: 11 (3): 789-806 
[46] Locke, M., Nichol, H., 1992. Iron economy in insects: Transport, metabolism, and 
storage. Annu. Rev. Entomol.: 37: 195-215 
[47] Van Agthoven, A., Goridis, C., Naquet, P., et al., 1984. Structural charateristics of the 
mouse transferrin receptor. Eur. J. Biochem.: 140 (2): 433-440 
[48] Pham, D.Q., Winzerling, J.J., 2010. Insect ferritins: Typical or atypical? Biochim. Biophys. 
Acta.: 1800 (8): 824-833 
[49] White, S., Taetle, R., Seligman, P.A., et al., 1990. Combinations of anti- transferrin 
receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: 
evidence for synergistic antiproliferative effects. Cancer Res.: 50 (19): 6295-6301 
[50] Liao, W., Lin, J. X., Leonard, W. J., 2001. IL-2 family cytokines: new insights into the 
complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin 
Immunol. 23 (5): 598-604 
[51] Malek, T.R., 2003. The main function of IL-2 is to promote the development of T 
regulatory cells. J. Leukoc. Biol.: 74 (6): 961-965 
[52] Scott, M.J., Godshall, C.J., Cheadle, W.G., 2002. Jaks, stats, cytokines, and sepsis. Clin 
Diagn Lab Immunol.: 9 (6): 1153-1159 
[53] Nelms, K., Keegan, A.D., Zamorano, J., et al., 1999. The IL-4 receptor: signaling 
mechanisms and biologic functions. Annu. Rev. Immunol.: 17: 701-738 
[54] Wynn, T.A., 2003. IL-13 Effector functions. Annu.Rev.Immunol.: 21: 425-456 
[55] Kolls, J.K., Lindén, A., 2004. Interleukin-17 family members and inflammation. Immunity: 
21 (4): 467-476 
[56] Kawaguchi, M., Adachi, M., Oda, N., et al., 2004. IL-17 cytokine family. J Allergy Clin 
Immunol: 114 (6): 1265-1273 
REFERENCES 
 
89 
 
[57] Jones, B.C., Logsdon, N.J., Walter, M.R., 2008. Structure of IL-22 bound to ist high 
affinity IL-22R1 chain. Structure: 16 (9): 1333-1344 
[58] Schroder, K., Hertzog, P.J., Ravasi, T., Hume, D.A., 2004. Interferon-γ: an overview of 
signals, mechanisms and functions. J. Leukoc. Biol.: 75 (2): 163-189 
[59] Shuai, K., Liu, B., 2003. Regulation of jak-stat signalling in the immune system. Nat. rev. 
Immunol.: 3 (11): 900-911 
[60] Li, M.O., Wan, Y.Y., Sanjabi, S., et al., 2006. Transforming growth factor- β regulation of 
immune responses. Annu. Rev. Immunol.: 24: 99-146 
[61] Letterio, J.J., Roberts, A.B., 1998. Regulation of immune respones by TGF-β. Annu. Rev. 
Immunol.: 16: 137-161 
[62] Neckers, L.M., Yenokida, G., James, S.P., 1984. The role of the transferrin receptor in 
human B lymphocyte activation. J. Immun.: 133 (5): 2437-2441 
[63] Ned, R.M., Swat, W., Andrews, N.C., 2003. Transferrin receptor 1 is differentially required 
in lymphocyte development. Blood: 102 (10): 3711-3718 
[64] Seligman, P.A., Kovar, J., Schleicher, R.B., Gelfand, E.W., 1991. transferrin- independent 
iron uptake supports B lymphocyte growth. Blood: 78 (6): 1526-1531 
[65] Brown, J.P., Hewick, R.M., Hellström, K.M., et al., 1982. Human melanoma-associated 
antigen p97 is structurally and functionally related to transferrin. Nature: 296 (5853): 171-
173 
[66] Thorstensen, K., Romsol, I., 1990. The role of transferrin in the mechanism of cellular iron 
uptake. Biochem. J.: 271 (1): 1-9 
[67] Chua, E., Clague, J.E., Sharma, A.K., et al., 1999. Serum transferrin receptor assay in 
iron deficiency anaemia and anaemia of chronic disease in the elderly. Q. J. Med.: 92 
(10): 587-594 
[68] Kaplan, J., Jordan, I., Sturrock, A., 1991. Regulation of the transferrin-independent iron 
transport system in cultured cells. J. Biol. Chem.: 266 (5): 2997-3004 
[69] Trowbridge, I.S., Domingo, D.L., 1981. Anti-transferrin receptor monoclonal antibody and 
toxin-antibody conjugates affect growth of human tumour cells. Nature 294 (5837): 171-
173 
[70] Trowbridge, I.S., Lopez, F., 1982. Monoclonal antibody to transferrin receptor blocks 
transferrin binding and inhhibits human tumor cell growth in vitro. Proc. Natl. Acad. Sci. 
USA: 79 (4): 1175-1179 
REFERENCES 
 
90 
 
[71] Mendelson, J., Trowbridge, I., Castagnola, J., 1983. Inhibition of human lymphocyte 
proliferation by monoclonal antibody to transferrin receptor. Blood: 62 (4): 821-826 
[72] Lesley, J.F., Schulte, R.J., 1985. Inhibition of cell growth by monolonal anti-transferrin 
receptor antibodies. Mol. Cell. Biol.: 5 (8): 1814-1821 
[73] Taetlee, R., Castagnola, J., Mendelsohn, J., 1986. Mechanisms of growth inhibition by 
anti-transferrin receptor monoclonal antibodies. Cancer Res.: 46 (4): 1759-1763 
[74] Knapp, W., Dörken, B., Rieber, R.E., et al., 1989. CD antigens 1989. IJC: 44 (1): 190-191 
[75] Besancon, F., Bourgeade, M.F., Testa, U., 1985. Inhibition of transferrin receptor 
expression by interferon-α in human lymphoblastoid cells and mitogen-induced 
lymphocytes. J. Biol. Chem.: 260 (24): 13074-13080 
[76] Karpova, M.B., Schoumans, J., Ernberg, I., et al., 2005. Raji revisited: cytogenetics of the 
original Burkitt`s lymphoma cell line. Leukemia: 19 (1): 159-161 
[77] Abraham, R.T., Weiss, A., 2004. Jurkat T cells and development of the T- cell receptor 
signalling paradigm. Nat. Rev. Immunol.: 4 (4): 301-308 
[78] McMichael, A J. (1987). Leucocyte Typing III. white Cell Differentiation Antigens. Oxford 
University Press. 
[79] Knapp, W. (1989). Fourth international workshop and conference on human leucocyte 
differentiation antigens. Vienna. Oxford University Press. 
[80] Barclay, A.N., Birkeland, M.L. (1993).The Leukocyte Antigen FactsBook. London. 
Academic press limited. 
[81] Nichol, H., Law, J.H., Winzerling, J.J., 2002. Iron metabolism in insects. Annu. Rev. 
Entomol.: 47: 535-559 
[82] Seemann C., 2004. Molekulare und funnktionelle charakterisierung des "13-344-antigens" 
auf dendritischen Zellen". Diploma thesis, Akademie für den medizinisch-technischen 
Laboratoriumsdienst am AKH der Stadt Wien. 
[83] Cella, M., Engering, A., Pinet, V., et al., 1997. Inflammatory stimuli induce accumulation 
of MHC class II complexes on dendritic cells. Nature: 388 (6644): 782-787 
[84] Leitner J, Grabmeier-Pfistershammer K, Steinberger P., 2010. Receptors and ligands 
implicated in human T cell costimulatory processes. Immunol. Lett.: 128 (2): 89-97. 
[85] Melián, A., Beckman, E.M., Porcelli, S.A., et al., 1996. Antigen presentation by CD1 and 
MHC-encoded class I-like  molecules. Curr. Opin. Immunol.: 8 (1): 82-88 
REFERENCES 
 
91 
 
[86] Hermandez, J.B., Newton, R.H., Walsh, C.M., 2010. Life and death in the thymus-cell 
death signaling during T cell development. Curr. Opin. Cell Biol.: 22 (6): 865-871 
[87] Lopez Guerrero, J.A., Redondo, J.M., Alarcón, B., et al., 1989. Different functional 
domains on the transferrin receptor molecule defined by monoclonal antibodies. 
Immunology: 66 (2): 252-257 
[88] Santtila, S., Savinainen, K., Hurme, M., 1998. Presence of the IL-1RA Allele 2 (IL1RN*2) 
is associated with enhanced IL-1β production in vitro. Scand. J. Immunol.: 47 (3): 195-
198 
[89] Kirchberger, S., Majdic, O., Blüml, S., et al., 2008. The cytoplasmic tail of CD45 is 
released from activated phagocytes and can act as an inhibitory messenger for T cells. 
Blood: 112 (4): 1240-1248 
 92 
 
8. CURRICULUM VITAE 
 
Personal data 
Name: Andreas Staudigl 
Date of birth: June, 1st, 1984 
Place of birth: Korneuburg, Austria 
Nationality:  Austria 
Residence: A-2103 Langenzersdorf 
E-mail: staudigl.andreas@gmail.com 
 
Education 
1991-1995 elementary school, VS Langenzersdorf 
1995-2003 Bundesgymnasium und Bundesrealgymnasium “Bertha 
von Suttner”, 1210 Vienna 
2003-2005 Bundesgymnasium, Bundesrealgymnasium und 
Wirtschaftskundliches Bundesrealgymnasiums für 
Berufstätige, Henriettenplatz 6, 1150 Vienna 
January 2005 Matura passed 
Since Otober 2006 studies in Genetics and Microbiology, 
University of Vienna, Austria 
July 2011- May 2012 diploma thesis at the Institute of Immunology, Medical 
University of Vienna 
 
Spoken languages: 
 German (native language) 
 English (fluently) 
 French (basic knowledge) 
 
